https://curecurrent.com/trials/evaluation-of-the-safety-and-efficacy-of-a-wideband-electric-pulse-tumor-ablation-system-for-malignant-pulmonary-nodules-43001https://curecurrent.com/trials/a-study-of-tiragolumab-plus-atezolizumab-compared-with-placebo-plus-atezolizumab-in-participants-with-completely-resecte-43002https://curecurrent.com/trials/adjuvant-therapy-for-high-risk-intrahepatic-cholangiocarcinoma-a-real-world-study-43003https://curecurrent.com/trials/a-study-to-learn-about-study-medicine-alta3263-in-adults-with-advanced-solid-tumors-with-kras-mutations-43004https://curecurrent.com/trials/the-efficacy-of-tislelizumab-combined-with-albumin-bound-paclitaxel-and-platinum-based-chemotherapy-in-patients-with-kra-43005https://curecurrent.com/trials/a-study-of-hdm2020-in-patients-with-advanced-sq-nsclc-43006https://curecurrent.com/trials/a-study-of-stereotactic-radiosurgery-srs-for-people-with-lung-cancer-that-has-spread-to-the-brain-43007https://curecurrent.com/trials/proof-of-concept-clinical-pharmacology-trial-for-covid-19-antigen-presentation-therapeutic-biologic-mix-43008https://curecurrent.com/trials/carboplatin-taxane-and-ramucirumab-for-patients-with-nsclc-after-pemetrexed-or-pembrolizumab-maintenance-43009https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-preliminary-antitumor-activity-of-inv-8989-in-patients-43010https://curecurrent.com/trials/a-phase-ii-trial-of-ak104-in-advanced-non-small-cell-lung-cancer-43011https://curecurrent.com/trials/tarlatamab-and-durvalumab-vs-durvalumab-alone-for-limited-stage-small-cell-lung-cancer-43012https://curecurrent.com/trials/using-ctdna-to-detect-minimal-residual-disease-after-lung-cancer-resection-43013https://curecurrent.com/trials/value-of-screening-mri-brain-in-stage-iv-non-small-cell-lung-cancer-43014https://curecurrent.com/trials/egfr-tkis-plus-pd-1-in-egfr-mutant-advanced-nsclc-43015https://curecurrent.com/trials/immune-metabolism-dysregulation-and-efficacy-to-anti-pd-1-pd-l1-agents-in-non-small-cell-lung-cancer-patients-43016https://curecurrent.com/trials/implementation-of-smoking-cessation-support-during-lung-cancer-workup-43017https://curecurrent.com/trials/ql1706-plus-anlotinib-as-a-later-line-treatment-for-patients-with-advanced-lung-cancer-43018https://curecurrent.com/trials/precision-exercise-prescription-for-lung-cancer-patients-undergoing-surgery-the-pep-study-43019https://curecurrent.com/trials/the-ease-study-randomized-trial-of-a-novel-approach-to-addressing-fear-of-progression-in-advanced-cancer-43020https://curecurrent.com/trials/investigation-of-the-effects-of-tele-yoga-training-in-individuals-with-lung-cancer-undergoing-lung-resection-surgery-43021https://curecurrent.com/trials/lung-map-nivolumab-with-or-without-ipilimumab-as-second-line-therapy-in-treating-patients-with-recurrent-stage-iv-squamo-43022https://curecurrent.com/trials/exercise-and-the-immune-response-in-lung-cancer-43023https://curecurrent.com/trials/comparing-palliative-radiotherapy-with-or-without-carboplatin-43024https://curecurrent.com/trials/screening-for-lung-cancer-in-subjects-with-family-history-of-lung-cancer-43025https://curecurrent.com/trials/the-selective-personalized-radio-immunotherapy-for-locally-advanced-non-small-cell-lung-cancer-trial-2-43026https://curecurrent.com/trials/vortioxetine-for-cognitive-function-in-alk-positive-nsclc-treated-with-lorlatinib-43027https://curecurrent.com/trials/a-study-of-biomarker-directed-pembrolizumab-mk-3475-based-combination-therapy-for-advanced-non-small-cell-lung-cancer-mk-43028https://curecurrent.com/trials/exploratory-study-on-the-efficacy-and-safety-of-trastuzumab-rezetecan-in-the-treatment-of-her2-expressiong-advanced-soli-43029https://curecurrent.com/trials/a-trial-to-compare-robotic-assisted-bronchoscopy-ion-s-clinical-utility-for-peripheral-lung-nodule-access-and-diagnosis-43030https://curecurrent.com/trials/a-study-of-hfb200603-as-a-single-agent-and-in-combination-with-tislelizumab-in-adult-patients-with-advanced-solid-tumors-43031https://curecurrent.com/trials/safety-and-efficacy-of-zimberelimab-ab122-in-combination-with-domvanalimab-ab154-and-etrumadenant-ab928-in-patients-with-43032https://curecurrent.com/trials/clinical-study-of-asciminib-in-previously-treated-indian-patients-with-ph-cml-cp-without-t315i-mutation-and-in-patients-43033https://curecurrent.com/trials/construction-and-feasibility-study-of-a-home-based-intelligent-symptom-management-program-for-lung-cancer-patients-recei-43034https://curecurrent.com/trials/nebulized-aer101-in-pre-op-nsclc-43035https://curecurrent.com/trials/comparing-photon-therapy-to-proton-therapy-to-treat-patients-with-lung-cancer-43036https://curecurrent.com/trials/intelligent-pulmonary-rehabilitation-after-lung-cancer-surgery-43037https://curecurrent.com/trials/lomustine-combined-with-anlotinib-as-interventional-therapy-for-extensive-stage-small-cell-lung-cancer-resistant-to-seco-43038https://curecurrent.com/trials/hypnosis-on-breathlessness-mastery-in-patients-with-persistent-dyspnea-43039https://curecurrent.com/trials/ctdna-mutations-and-methylation-status-for-early-detection-of-lung-cancer-in-patients-with-suspicious-lung-nodules-43040https://curecurrent.com/trials/methylated-biomarkers-of-smoking-as-a-selection-tool-in-participants-for-lung-cancer-screening-43041https://curecurrent.com/trials/organ-specific-differences-in-immunotherapy-response-among-metastatic-cancer-patients-43042https://curecurrent.com/trials/maintenance-lurbinectedin-in-combination-with-serplulimab-for-patients-with-es-sclc-43043https://curecurrent.com/trials/maintenance-chemotherapy-with-or-without-local-consolidative-therapy-in-treating-patients-with-stage-iv-non-small-cell-l-43044https://curecurrent.com/trials/single-center-intelligent-pulmonary-rehabilitation-after-lung-cancer-surgery-43045https://curecurrent.com/trials/assessment-of-the-safety-and-efficacy-of-balstilimab-in-combination-with-botensilimab-for-the-treatment-of-non-small-cel-43046https://curecurrent.com/trials/ko-2806-monotherapy-and-combination-therapies-in-advanced-solid-tumors-43047https://curecurrent.com/trials/trastuzumab-rezetecan-shr-a1811-combined-with-ivonescimab-ak112-in-locally-advanced-or-metastatic-non-small-cell-lung-ca-43048https://curecurrent.com/trials/safety-efficacy-of-consolidative-hypofractionated-radiation-therapy-for-boosting-residual-lung-cancer-with-durvalumab-43049https://curecurrent.com/trials/association-of-thoraco-mediastinal-radiotherapy-with-maintenance-immunotherapy-treatment-with-atezolizumab-43050https://curecurrent.com/trials/boosting-osimertinib-blood-brain-barrier-penetration-43051https://curecurrent.com/trials/a-study-of-plb1001-in-non-small-cell-lung-cancer-with-c-met-dysregulation-kunpeng-43052https://curecurrent.com/trials/integration-of-the-pd-l1-inhibitor-atezolizumab-and-wt1-dc-vaccination-into-platinum-pemetrexed-based-first-line-treatme-43053https://curecurrent.com/trials/implementing-low-dose-ct-lung-cancer-screening-in-france-43054https://curecurrent.com/trials/testing-maintenance-therapy-for-small-cell-lung-cancer-in-patients-with-slfn11-positive-biomarker-43055https://curecurrent.com/trials/safety-and-feasibility-of-intraoperative-visualization-with-cytalux-in-children-43056https://curecurrent.com/trials/standardization-of-a-platform-of-preclinical-models-derived-from-nsclc-patients-43057https://curecurrent.com/trials/clinical-study-to-identify-biomarkers-for-tumor-spread-through-air-spaces-status-43058https://curecurrent.com/trials/a-phase-i-ii-study-of-bexarotene-in-combination-with-zd1839-iressa-in-the-treatment-of-non-small-cell-lung-cancer-43059https://curecurrent.com/trials/dose-finding-and-dose-expansion-study-of-ose-279-in-subjects-with-advanced-solid-tumors-or-lymphomas-43060https://curecurrent.com/trials/australian-retrospective-analysis-of-egfrm-advanced-metastatic-nsclc-patients-treated-with-1l-or-2l-osimertinib-43061https://curecurrent.com/trials/phase-ii-study-of-upfront-srt-plus-ivonescimab-chemotherapy-vs-ivonescimab-chemotherapy-in-nsclc-brain-mets-43062https://curecurrent.com/trials/increasing-physical-activity-through-personalised-motivational-messaging-to-improve-cognitive-function-in-lung-cancer-su-43063https://curecurrent.com/trials/safety-and-preliminary-activity-of-bi115-in-advanced-sclc-43064https://curecurrent.com/trials/biomarkers-for-risk-stratification-in-lung-cancer-43065https://curecurrent.com/trials/expanded-access-to-ulixertinib-bvd-523-in-patients-with-advanced-mapk-pathway-altered-malignancies-43066https://curecurrent.com/trials/pf-07284892-in-participants-with-advanced-solid-tumors-43067https://curecurrent.com/trials/association-between-screening-behaviors-and-lung-cancer-spectrum-43068https://curecurrent.com/trials/an-efficacy-and-safety-study-of-cofetuzumab-pelidotin-in-participants-with-ptk7-expressing-recurrent-non-small-cell-lung-43069https://curecurrent.com/trials/becotatug-vedotin-combined-with-pucotenlimab-radiotherapy-as-first-line-treatment-for-driver-gene-negative-egfr-expressi-43070https://curecurrent.com/trials/a-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-hlx43-serplulimab-as-neoadjuvant-therapy-in-subjects-with-nsclc-43071https://curecurrent.com/trials/evaluating-the-efficacy-and-safety-of-ai-localization-models-in-multidisciplinary-team-care-for-nsclc-43072https://curecurrent.com/trials/efficacy-safety-of-olvimulogene-nanivacirepvec-platinum-doublet-physician-s-choice-of-immune-checkpoint-inhibitor-compar-43073https://curecurrent.com/trials/study-of-pf-07265807-in-participants-with-metastatic-solid-tumors-43074https://curecurrent.com/trials/impact-of-a-reminder-app-on-physical-activity-during-radiation-therapy-for-lung-cancer-43075https://curecurrent.com/trials/study-with-abbv-cls-484-in-participants-with-locally-advanced-or-metastatic-tumors-43076https://curecurrent.com/trials/study-of-pembrolizumab-and-single-agent-chemotherapy-as-first-line-treatment-for-patients-with-locally-advanced-or-metas-43077https://curecurrent.com/trials/mage-a4-t-for-multi-tumor-43078https://curecurrent.com/trials/study-of-rmc-9805-in-participants-with-kras-g12d-mutant-solid-tumors-43079https://curecurrent.com/trials/blood-based-risk-evaluation-with-ai-for-targeted-primary-health-care-in-early-lung-cancer-detection-43080https://curecurrent.com/trials/firmonertinib-in-perioperative-treatment-of-resectable-stage-ii-iiib-egfr-mutated-lung-adenocarcinoma-43081https://curecurrent.com/trials/quaratusugene-ozeplasmid-reqorsa-in-combination-with-pembrolizumab-in-previously-treated-non-small-lung-cancer-43082https://curecurrent.com/trials/the-lung-pca-a-multi-dimensional-atlas-of-pulmonary-premalignancy-43083https://curecurrent.com/trials/a-study-of-atezolizumab-and-tiragolumab-compared-with-durvalumab-in-participants-with-locally-advanced-unresectable-stag-43084https://curecurrent.com/trials/a-study-of-tiragolumab-in-combination-with-atezolizumab-plus-pemetrexed-and-carboplatin-cisplatin-versus-pembrolizumab-p-43085https://curecurrent.com/trials/study-of-the-efficacy-and-safety-of-ponsegromab-in-patients-with-cancer-cachexia-and-elevated-gdf-15-43086https://curecurrent.com/trials/translational-research-center-in-lung-cancer-disparities-tracer-project-2-43087https://curecurrent.com/trials/study-of-lt-010391-in-participants-with-kras-g12d-mutant-solid-tumors-43088https://curecurrent.com/trials/non-invasive-malignancy-classifiers-using-blood-biomarkers-for-lung-nodule-evaluation-43089https://curecurrent.com/trials/effect-of-time-of-day-tod-for-immunochemotherapy-on-pfs-in-nsclc-43090https://curecurrent.com/trials/mechanism-of-enhanced-efficacy-of-ivonescimab-in-neoadjuvant-therapy-for-non-small-cell-lung-cancer-43091https://curecurrent.com/trials/comparing-combinations-of-targeted-drugs-for-advanced-non-small-cell-lung-cancer-that-has-egfr-and-met-gene-changes-a-lu-43092https://curecurrent.com/trials/response-of-bony-metastasis-to-tyrosine-kinase-inhibitors-in-non-small-cell-lung-cancers-with-actionable-driver-mutation-43093https://curecurrent.com/trials/spi-1005-for-prevention-and-treatment-of-chemotherapy-induced-hearing-loss-43094https://curecurrent.com/trials/exploratory-study-of-inhaled-afatinib-dimaleate-pk-profile-43095https://curecurrent.com/trials/visualising-c-met-and-activated-neutrophils-in-lung-cancer-43096https://curecurrent.com/trials/the-effect-of-covid-19-pandemic-on-adolescent-and-young-adult-cancer-patients-and-survivors-43097https://curecurrent.com/trials/impact-of-chemotherapy-dose-reductions-on-survival-outcomes-among-older-nsclc-patients-without-actionable-mutations-43098https://curecurrent.com/trials/study-to-test-the-safety-and-tolerability-of-pf-07257876-in-participants-with-selected-advanced-tumors-43099https://curecurrent.com/trials/a-study-of-effectiveness-and-safety-of-the-first-line-nivolumab-plus-ipilimumab-with-or-without-chemotherapy-for-advance-43100https://curecurrent.com/trials/shr-1701-for-induction-and-consolidation-therapy-in-unresectable-stage-iii-non-small-cell-lung-cancer-43101https://curecurrent.com/trials/reduced-ct-anti-pd-1-as-first-line-tx-in-vulnerable-older-adults-w-adv-50-pd-l1-non-small-cell-lung-cancer-nsclc-43102https://curecurrent.com/trials/physical-activity-during-radiation-therapy-for-lung-cancer-43103https://curecurrent.com/trials/bbo-11818-in-adult-subjects-with-kras-mutant-cancer-43104https://curecurrent.com/trials/assessment-of-a-radiomics-based-computer-aided-diagnosis-tool-for-pulmonary-nodules-43105https://curecurrent.com/trials/a-phase-i-study-of-hs-20108-in-participants-with-advanced-solid-tumors-43106https://curecurrent.com/trials/multinational-observational-study-to-describe-diagnostic-stage-shift-in-patients-with-lung-cancer-using-medical-records-43107https://curecurrent.com/trials/strategy-for-early-recognition-of-cancer-copd-heart-failure-in-the-emergency-department-43108https://curecurrent.com/trials/the-efficacy-and-safety-of-fosrolapitant-and-palonosetron-hydrochloride-for-injection-in-preventing-nausea-and-vomiting-43109https://curecurrent.com/trials/lunar-4-effect-of-tumor-treating-fields-ttfields-150-khz-concurrent-with-pembrolizumab-for-treatment-of-metastatic-non-s-43110https://curecurrent.com/trials/a-post-approval-commitment-study-on-tabrecta-capmatinib-in-south-korea-43111https://curecurrent.com/trials/a-retrospective-analysis-of-statin-use-and-outcome-after-thoracic-cancer-surgery-43112https://curecurrent.com/trials/selective-mediastinal-lymph-node-sampling-versus-systematic-mediastinal-lymph-node-dissection-after-neoadjuvant-chemoimm-43113https://curecurrent.com/trials/study-of-novel-treatment-combinations-in-patients-with-lung-cancer-43114https://curecurrent.com/trials/intermittent-hypoxic-training-as-neoadjuvant-therapy-for-lung-squamous-cell-carcinoma-43115https://curecurrent.com/trials/a-global-phase-ii-iii-clinical-study-to-evaluate-the-efficacy-and-safety-of-hlx43-monotherapy-or-hlx43-in-combination-wi-43116https://curecurrent.com/trials/mass-spectral-fingerprinting-in-lung-cancer-43117https://curecurrent.com/trials/study-with-various-immunotherapy-treatments-in-participants-with-lung-cancer-43118https://curecurrent.com/trials/macrophage-imaging-using-ga-mmr-vhh2-in-lung-cancer-patients-43119https://curecurrent.com/trials/safety-and-efficacy-study-of-investigational-agents-as-monotherapy-or-in-combination-with-pembrolizumab-mk-3475-for-the-43120https://curecurrent.com/trials/integrating-telehealth-to-advance-lung-cancer-screening-43121https://curecurrent.com/trials/safety-and-tolerability-of-cvhnlc-plus-pembrolizumab-in-patients-with-squamous-non-small-cell-lung-cancer-sqnsclc-43122https://curecurrent.com/trials/prospective-cohort-study-evaluating-18fdg-pet-ct-for-the-early-prediction-of-the-efficacy-of-immunotherapy-associated-or-43123https://curecurrent.com/trials/educational-intervention-for-patients-undergoing-surgery-for-lung-cancer-43124https://curecurrent.com/trials/stereotactic-body-radiation-therapy-planning-with-artificial-intelligence-directed-dose-recommendation-for-treatment-of-43125https://curecurrent.com/trials/assessment-of-4d-18f-fdg-pet-ct-in-radiotherapy-for-non-small-cell-lung-cancers-43126https://curecurrent.com/trials/niraparib-added-to-anti-pd-l1-antibody-maintenance-in-slfn11-positive-extensive-disease-sclc-43127https://curecurrent.com/trials/a-feasibility-study-to-further-the-development-of-lung-cancer-based-precision-medicine-43128https://curecurrent.com/trials/study-of-ly3537982-in-cancer-patients-with-a-specific-genetic-mutation-kras-g12c-43129https://curecurrent.com/trials/a-study-to-learn-about-dacomitinib-in-patients-with-non-small-cell-lung-cancer-43130https://curecurrent.com/trials/a-study-comparing-alectinib-with-crizotinib-in-treatment-naive-anaplastic-lymphoma-kinase-positive-advanced-non-small-ce-43131https://curecurrent.com/trials/alcmi-005-pembrolizumab-and-epacadostat-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-43132https://curecurrent.com/trials/trop2-targeted-immunopet-imaging-of-solid-tumors-43133https://curecurrent.com/trials/sputum-cytometry-analysis-in-lung-cancer-screening-after-professional-asbestos-exposure-43134https://curecurrent.com/trials/an-educational-intervention-lung-toolkit-for-improving-knowledge-about-lung-cancer-and-screening-among-american-indian-a-43135https://curecurrent.com/trials/support-and-outreach-to-increase-screening-for-lung-cancer-in-patients-with-a-history-of-smoking-43136https://curecurrent.com/trials/virtual-agent-feasibility-in-oncology-patients-ntt-data-43137https://curecurrent.com/trials/sub-lobectomy-vs-lobectomy-in-iia-iiib-nsclc-after-neoadjuvant-io-chemo-43138https://curecurrent.com/trials/hypofractionated-vs-conventionally-fractionated-concurrent-crt-for-ld-sclc-43139https://curecurrent.com/trials/neoadjuvant-sf-sbrt-plus-toripalimab-and-chemotherapy-in-resectable-stage-ii-iii-nsclc-43140https://curecurrent.com/trials/a-phase-2-study-of-eik1001-in-combo-with-pembrolizumab-and-chemotherapy-in-patients-with-stage-4-nsclc-43141https://curecurrent.com/trials/effect-of-arm-cycling-exercise-on-pulmonary-functions-after-colectomy-in-elderly-43142https://curecurrent.com/trials/a-study-of-anvumetostat-in-participants-with-advanced-mtap-null-solid-tumors-mtapestry-101-43143https://curecurrent.com/trials/study-on-the-mechanism-of-adc-drug-evaluation-based-on-immune-co-culture-of-lung-cancer-organoids-43144https://curecurrent.com/trials/a-study-of-tumor-treating-fields-ttfields-in-people-with-lung-adenocarcinoma-43145https://curecurrent.com/trials/anvumetostat-alone-or-in-combination-with-other-therapies-in-subjects-with-advanced-thoracic-tumors-with-homozygous-mtap-43146https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-efficacy-of-bms-986523-alone-and-in-combination-with-anti-cancer-agents-43147https://curecurrent.com/trials/new-york-better-breathing-study-43148https://curecurrent.com/trials/a-study-of-nivolumab-ipilimumab-and-chemotherapy-in-participants-with-non-small-cell-lung-cancer-43149https://curecurrent.com/trials/a-study-of-sacituzumab-govitecan-in-people-with-mesothelioma-43150https://curecurrent.com/trials/telehealth-collaborative-care-model-cocm-in-lung-cancer-43151https://curecurrent.com/trials/clinical-application-of-pet-imaging-targeting-msln-in-malignant-tumors-43152https://curecurrent.com/trials/honokiol-in-early-stage-resectable-non-small-cell-lung-cancer-43153https://curecurrent.com/trials/a-phase-2-study-of-anvumetostat-in-participants-with-mtap-deleted-advanced-nsclc-mtapestry-201-43154https://curecurrent.com/trials/evaluation-of-prevalence-and-risk-factors-of-persistent-covid-19-in-immunocompromised-patients-43155https://curecurrent.com/trials/study-of-kn046-in-subjects-with-advanced-non-small-cell-lung-cancer-43156https://curecurrent.com/trials/characterizing-chemo-radiotherapy-treatment-related-cardiac-changes-43157https://curecurrent.com/trials/a-clinical-study-of-sctb41-combined-with-docetaxel-in-patients-with-previously-treated-locally-advanced-or-metastatic-no-43158https://curecurrent.com/trials/a-study-of-repotrectinib-tpx-0005-in-patients-with-advanced-solid-tumors-harboring-alk-ros1-or-ntrk1-3-rearrangements-43159https://curecurrent.com/trials/study-on-savolitinib-combined-with-osimertinib-in-treatment-of-advanced-nsclc-with-met-amplification-43160https://curecurrent.com/trials/evolution-of-the-therapeutic-care-in-lung-cancer-in-france-since-2015-esme-lc-43161https://curecurrent.com/trials/crt-chemo-radiation-therapy-patterns-and-short-term-outcomes-on-unresectable-nsclc-and-sclc-in-routine-practices-in-russ-43162https://curecurrent.com/trials/pembrolizumab-after-radiation-therapy-in-treating-patients-with-pleural-malignant-mesothelioma-43163https://curecurrent.com/trials/neoadjuvant-immunoradiation-for-resectable-non-small-cell-lung-cancer-43164https://curecurrent.com/trials/a-phase-ib-ii-study-of-an-anti-her3-antibody-hmbd-001-with-cetuximab-docetaxel-in-advanced-squamous-cell-cancers-43165https://curecurrent.com/trials/immuno-lung-identification-of-biomarkers-and-therapeutic-targets-for-pulmonary-immunotherapy-43166https://curecurrent.com/trials/a-study-of-dzd9008-versus-platinum-based-doublet-chemotherapy-in-local-advanced-or-metastatic-non-small-cell-lung-cancer-43167https://curecurrent.com/trials/segmentectomy-after-induction-therapy-saint-43168https://curecurrent.com/trials/a-ctdna-guided-phase-ii-trial-of-osimertinib-in-combination-with-sacituzumab-tirumotecan-in-egfr-mutated-advanced-nsclc-43169https://curecurrent.com/trials/nogapendekin-alfa-inbakicept-for-advanced-non-small-cell-lung-cancer-43170https://curecurrent.com/trials/avoiding-radiation-therapy-due-to-intracranial-response-to-chemotherapy-targeted-therapy-and-or-immuno-oncology-therapy-43171https://curecurrent.com/trials/icare-lcs-queri-partnered-evaluation-initiative-integrating-comprehensive-tobacco-treatment-to-enhance-lung-cancer-scree-43172https://curecurrent.com/trials/testing-of-the-anti-cancer-drugs-cb-839-hcl-telaglenastat-and-mln0128-sapanisertib-in-advanced-stage-non-small-cell-lung-43173https://curecurrent.com/trials/nutritional-usual-corticosteroids-randomized-trial-for-immune-related-pneumonia-therapeutic-utilization-evaluation-43174https://curecurrent.com/trials/drp-104-in-patients-with-nfe2l2-keap1-altered-non-small-cell-lung-cancer-43175https://curecurrent.com/trials/iscador-p-mistletoe-immunotherapy-for-recurrent-resectable-osteogenic-sarcoma-43176https://curecurrent.com/trials/prospective-phase-ii-clinical-study-of-stereotactic-body-proton-therapy-sbpt-for-lung-cancer-43177https://curecurrent.com/trials/a-trial-of-hrs-7058-in-advanced-or-metastatic-non-small-cell-lung-cancer-patients-who-have-failed-standard-treatment-43178https://curecurrent.com/trials/db-1311-in-combination-with-bnt327-or-db-1305-in-advanced-metastatic-solid-tumors-43179https://curecurrent.com/trials/ibrutinib-for-the-prevention-of-chronic-graft-versus-host-disease-in-patients-undergoing-donor-stem-cell-transplant-43180https://curecurrent.com/trials/pm8002-in-combination-with-paclitaxel-compared-with-chemotherapy-as-second-line-treatment-in-small-cell-lung-cancer-43181https://curecurrent.com/trials/sintilimab-plus-chemotherapy-as-induction-therapy-for-unresectable-stage-iiic-nsclc-43182https://curecurrent.com/trials/dose-attenuated-chemotherapy-in-compromised-patients-with-lung-cancer-43183https://curecurrent.com/trials/a-clinico-biological-database-of-lung-cancers-43184https://curecurrent.com/trials/scoot-sample-collection-for-dart-43185https://curecurrent.com/trials/a-study-investigating-bg-60366-in-adults-with-epidermal-growth-factor-receptor-egfr-mutant-non-small-cell-lung-cancer-43186https://curecurrent.com/trials/phase-ii-randomized-trial-of-carboplatin-pemetrexed-bevacizumab-atezolizumab-in-stage-iv-nsclc-43187https://curecurrent.com/trials/a-study-to-learn-about-the-study-medicine-pf-07985045-when-given-alone-or-with-other-anti-cancer-therapies-in-people-wit-43188https://curecurrent.com/trials/mdt-bridged-radical-therapy-after-aumolertinib-with-mrd-guided-maintenance-in-egfrm-unresectable-stage-iii-nsclc-approac-43189https://curecurrent.com/trials/phase-ii-clinical-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-antitumor-activity-of-alk202-for-inject-43190https://curecurrent.com/trials/a-phase-study-assessing-the-safety-and-efficacy-of-plb1004-in-egfr-ex20ins-mutation-patients-with-advanced-and-metastati-43191https://curecurrent.com/trials/a-study-of-jmt203-in-patients-with-cancer-cachexia-43192https://curecurrent.com/trials/nivolumab-plus-ramucirumab-in-patients-with-recurrent-advanced-metastatic-nsclc-43193https://curecurrent.com/trials/ceritinib-and-everolimus-in-treating-patients-with-locally-advanced-or-metastatic-solid-tumors-or-stage-iiib-iv-non-smal-43194https://curecurrent.com/trials/a-single-arm-open-label-phase-ii-study-to-evaluate-efficacy-safety-and-pharmacokinetics-of-hlx10-chemotherapy-in-patient-43195https://curecurrent.com/trials/integrative-multi-omics-testing-for-immunotherapy-response-in-non-small-cell-lung-cancer-43196https://curecurrent.com/trials/peripheral-vascular-disease-as-a-clinical-trigger-for-opportunistic-lung-cancer-screening-referral-an-implementation-stu-43197https://curecurrent.com/trials/oral-paclitaxel-as-neoadjuvant-therapy-in-elderly-nsclc-a-phase-ii-trial-43198https://curecurrent.com/trials/diagnosing-peripheral-lung-lesions-with-cryo-biopsies-43199https://curecurrent.com/trials/post-operative-prediction-of-pulmonary-function-43200https://curecurrent.com/trials/a-retrospective-observational-study-of-nivolumab-in-combination-with-chemotherapy-as-neoadjuvant-therapy-for-resectable-43201https://curecurrent.com/trials/a-exploratory-study-of-nivolumab-monotherapy-or-in-combination-with-nab-paclitaxel-and-carboplatin-in-early-stage-nsclc-43202https://curecurrent.com/trials/camrelizumab-combined-with-srt-wbrt-and-chemotherapy-in-patients-with-brain-metastases-of-driven-gene-negative-nsclc-43203https://curecurrent.com/trials/nivolumab-and-radiation-therapy-with-or-without-ipilimumab-in-treating-patients-with-brain-metastases-from-non-small-cel-43204https://curecurrent.com/trials/markerless-image-guidance-using-intrafraction-kilovoltage-x-ray-imaging-43205https://curecurrent.com/trials/study-of-tarlatamab-in-combination-with-yl201-with-or-without-anti-programmed-death-ligand-1-pd-l1-in-participants-with-43206https://curecurrent.com/trials/patient-perceptions-of-the-relational-empathy-of-healthcare-practitioners-from-the-department-of-emergency-medicine-duri-43207https://curecurrent.com/trials/analysis-of-different-second-line-treatment-in-advanced-nsclc-patients-progressing-after-1st-line-immune-checkpoint-inhi-43208https://curecurrent.com/trials/respiratory-adaptive-computed-tomography-feasibility-study-on-real-time-gated-4dct-for-lung-cancer-radiotherapy-43209https://curecurrent.com/trials/serplulimab-monotherapy-in-elderly-patients-with-nsclc-and-pd-l1-tps-50-43210https://curecurrent.com/trials/a-single-dose-open-label-dose-escalation-study-of-the-safety-and-imaging-characteristics-of-ls301-it-for-intraoperative-43211https://curecurrent.com/trials/phase-3-study-of-taletrectinib-vs-placebo-as-an-adjuvant-therapy-in-ros1-positive-nsclc-trust-iv-43212https://curecurrent.com/trials/ventilation-imaging-to-improve-the-quality-of-life-for-patients-with-lung-cancer-treated-with-radiation-therapy-43213https://curecurrent.com/trials/clinical-study-on-the-effects-of-pulmonary-vessels-on-cryoablation-and-preventive-embolization-strategies-43214https://curecurrent.com/trials/dose-escalation-expansion-study-of-mavrostobart-pt199-an-anti-cd73-mab-administered-alone-and-in-combination-with-a-pd-1-43215https://curecurrent.com/trials/construction-and-preliminary-evaluation-of-dyadic-acceptance-and-commitment-therapy-for-couples-with-fear-of-lung-cancer-43216https://curecurrent.com/trials/tumor-informed-mrd-for-non-small-cell-lung-cancer-43217https://curecurrent.com/trials/application-of-electromagnetic-navigation-system-in-pulmonary-nodule-localization-43218https://curecurrent.com/trials/safety-and-efficacy-of-combination-osimertinib-and-ipilimumab-in-patients-w-egfr-mutated-nsclc-43219https://curecurrent.com/trials/ventilation-using-radiographic-examination-functional-lung-imaging-techniques-for-the-reduction-of-toxicity-in-functiona-43220https://curecurrent.com/trials/18f-fibroblast-activation-protein-inhibitor-18f-fapi-74-pet-imaging-for-cancer-detection-43221https://curecurrent.com/trials/docetaxel-plinabulin-compared-to-docetaxel-placebo-in-patients-with-advanced-nsclc-43222https://curecurrent.com/trials/statewide-unified-network-for-remote-intervention-of-strength-and-exercise-43223https://curecurrent.com/trials/a-study-of-lorlatinib-in-subjects-with-ros1-positive-non-small-cell-lung-cancer-43224https://curecurrent.com/trials/combinations-of-cemiplimab-anti-pd-1-antibody-and-platinum-based-doublet-chemotherapy-in-patients-with-lung-cancer-43225https://curecurrent.com/trials/sar408701-versus-docetaxel-in-previously-treated-carcinoembryonic-antigen-related-cell-adhesion-molecule-5-ceacam5-posit-43226https://curecurrent.com/trials/s1403-afatinib-dimaleate-with-or-without-cetuximab-in-treating-patients-with-newly-diagnosed-stage-iv-or-recurrent-egfr-43227https://curecurrent.com/trials/a-study-of-ivonescimab-in-people-with-non-small-cell-lung-cancer-43228https://curecurrent.com/trials/study-of-treatment-with-sacituzumab-and-zimberelimab-for-patients-with-lung-cancer-confined-to-the-chest-and-previously-43229https://curecurrent.com/trials/preoperative-decision-making-in-patients-with-pulmonary-nodules-suspected-of-lung-cancer-43230https://curecurrent.com/trials/testing-the-use-of-combination-immunotherapy-treatment-n-803-alt-803-plus-pembrolizumab-against-the-usual-treatment-for-43231https://curecurrent.com/trials/a-study-of-dcty1102-injection-in-participants-with-advanced-solid-tumors-43232https://curecurrent.com/trials/covid19-outcomes-in-myeloma-and-the-impact-of-vaccines-43233https://curecurrent.com/trials/evaluating-the-impact-of-centralized-interventions-on-lung-cancer-screening-adherence-in-community-settings-accell-trial-43234https://curecurrent.com/trials/xr-assisted-pet-ct-navigation-for-cervical-lymph-node-dissection-in-lung-cancer-43235https://curecurrent.com/trials/lung-map-a-master-screening-protocol-for-previously-treated-non-small-cell-lung-cancer-43236https://curecurrent.com/trials/a-phase-ii-clinical-study-evaluating-the-combination-therapy-of-js212-in-patients-with-advanced-lung-cancer-43237https://curecurrent.com/trials/mylung-consortium-study-protocol-2-43238https://curecurrent.com/trials/mylung-consortium-part-3-observational-study-43239https://curecurrent.com/trials/phase-ii-clinical-study-of-js207-pd-1-vegf-bispecific-antibody-combination-therapies-in-patients-with-driver-gene-positi-43240https://curecurrent.com/trials/respiratory-muscle-training-before-surgery-in-preventing-lung-complications-in-patients-with-stage-i-iiib-lung-cancer-43241https://curecurrent.com/trials/a-study-to-find-a-suitable-dose-of-asp5834-in-adults-with-solid-tumors-43242https://curecurrent.com/trials/real-world-comparison-of-chemo-immunotherapy-regimens-in-metastatic-nsclc-with-pd-l1-50-alcg-01-43243https://curecurrent.com/trials/ceritinib-plus-docetaxel-in-alk-negative-egfr-wt-advanced-nsclc-43244https://curecurrent.com/trials/indian-lung-screening-trial-43245https://curecurrent.com/trials/pembrolizumab-and-stereotactic-body-radiation-therapy-or-non-stereotactic-wide-field-radiation-therapy-in-treating-patie-43246https://curecurrent.com/trials/study-of-rmc-6236-in-patients-with-advanced-solid-tumors-harboring-specific-mutations-in-ras-43247https://curecurrent.com/trials/study-of-autologous-tumor-infiltrating-lymphocytes-in-patients-with-solid-tumors-43248https://curecurrent.com/trials/datopotamab-deruxtecan-dato-dxd-in-combination-with-pembrolizumab-with-or-without-platinum-chemotherapy-in-subjects-with-43249https://curecurrent.com/trials/expanded-access-program-eap-designed-to-provide-access-to-botensilimab-and-balstilimab-before-regulatory-approval-43250https://curecurrent.com/trials/piloting-a-virtual-navigation-vn-system-for-bronchoscopic-lung-nodule-sampling-43251https://curecurrent.com/trials/a-study-to-investigate-the-effects-of-durvalumab-with-oleclumab-following-chemoradiation-in-participants-with-locally-ad-43252https://curecurrent.com/trials/promoting-radon-testing-among-mothers-of-young-children-43253https://curecurrent.com/trials/first-in-human-expanded-cohort-study-of-intrapleural-administration-of-toluenesulfonamide-in-patients-with-malignant-ple-43254https://curecurrent.com/trials/multimodal-ai-guided-recovery-management-after-lung-cancer-surgery-43255https://curecurrent.com/trials/study-of-pembrolizumab-with-concurrent-chemoradiation-therapy-followed-by-pembrolizumab-with-or-without-olaparib-in-stag-43256https://curecurrent.com/trials/a-reminder-app-to-improve-physical-activity-during-radiotherapy-for-lung-cancer-a-pre-study-in-healthy-volunteers-43257https://curecurrent.com/trials/does-pep-compensate-the-reduction-of-tidal-volume-during-one-lung-ventilation-43258https://curecurrent.com/trials/singapore-lung-cancer-screening-through-integrating-ct-with-other-biomarkers-solstice-43259https://curecurrent.com/trials/evaluation-of-the-utility-of-rapid-on-site-cytology-performed-by-an-interventional-pulmonologist-during-ebus-tbna-43260https://curecurrent.com/trials/dose-escalation-and-dose-expansion-study-of-rmc-6291-monotherapy-in-subjects-with-advanced-krasg12c-mutant-solid-tumors-43261https://curecurrent.com/trials/an-endotracheal-tube-inserted-to-the-level-of-the-hypopharynx-43262https://curecurrent.com/trials/e-health-supported-preoperative-education-43263https://curecurrent.com/trials/egfr-mutated-lung-cancer-in-randomized-investigator-initiated-study-43264https://curecurrent.com/trials/a-study-to-evaluate-two-dosing-regimens-of-subcutaneous-nivolumab-in-combination-with-intravenous-ipilimumab-and-chemoth-43265https://curecurrent.com/trials/a-study-to-evaluate-the-benefit-of-adding-durvalumab-after-chemotherapy-durvalumab-and-surgery-in-patients-with-early-st-43266https://curecurrent.com/trials/a-study-of-mobocertinib-in-japanese-adults-with-non-small-cell-lung-cancer-43267https://curecurrent.com/trials/psilocybin-assisted-therapy-for-the-treatment-of-major-depressive-disorder-in-patients-with-non-small-cell-lung-cancer-43268https://curecurrent.com/trials/a-study-to-investigate-the-efficacy-and-safety-of-dato-dxd-with-or-without-osimertinib-compared-with-platinum-based-doub-43269https://curecurrent.com/trials/analysis-of-screen-detected-lung-cancers-genomic-traits-43270https://curecurrent.com/trials/study-to-evaluate-the-safety-tolerability-efficacy-of-tng462-in-combination-in-pdac-nsclc-patients-43271https://curecurrent.com/trials/endobronchial-ultrasound-guided-interstitial-photodynamic-therapy-in-treating-patients-with-locally-advanced-lung-cancer-43272https://curecurrent.com/trials/nano-smart-nanoparticles-with-mr-guided-sbrt-in-centrally-located-lung-tumors-and-pancreatic-cancer-43273https://curecurrent.com/trials/self-management-support-for-lung-cancer-patients-with-cachexia-43274https://curecurrent.com/trials/a-phase-1-first-in-human-study-of-crpa1a2-a-mage-a1-hla-a-02-01-bispecific-t-cell-engager-in-patients-with-solid-tumors-43275https://curecurrent.com/trials/teniposide-cisplatin-and-serplulimab-for-treatment-of-es-sclc-a-randomized-controlled-study-43276https://curecurrent.com/trials/study-assessing-pet-imaging-with-zirconium-labelled-girentuximab-in-patients-with-hcc-btc-or-nen-43277https://curecurrent.com/trials/testing-of-tazemetostat-in-combination-with-topotecan-and-pembrolizumab-in-patients-with-recurrent-small-cell-lung-cance-43278https://curecurrent.com/trials/confocal-laser-endomicroscopy-nodule-localization-by-robotic-bronchoscopy-43279https://curecurrent.com/trials/phase-2b-safety-and-efficacy-study-of-vgt-309-in-subjects-with-cancer-in-the-lung-43280https://curecurrent.com/trials/3d-virtual-resection-for-predicting-lung-function-in-vats-43281https://curecurrent.com/trials/a-phase-ii-trial-of-lm103-for-adjuvant-treatment-in-patients-with-non-small-cell-lung-cancer-43282https://curecurrent.com/trials/denila-comprehensive-demographics-and-clinical-profile-of-nsclc-patients-analyzing-guideline-concordant-care-in-first-li-43283https://curecurrent.com/trials/a-phase-study-of-cs08399-in-participants-with-mtap-deleted-solid-tumors-and-lymphoma-43284https://curecurrent.com/trials/plasma-molecular-profiling-in-alk-inhibitor-resistant-nsclc-43285https://curecurrent.com/trials/clinical-study-on-the-prevention-of-driver-gene-negative-ib-iiib-lung-cancer-recurrence-and-metastasis-by-staged-chinese-43286https://curecurrent.com/trials/a-phase-ii-clinical-trial-of-shr-1826-for-non-small-cell-lung-cancer-43287https://curecurrent.com/trials/comparison-of-68ga-fapi-46-pet-and-18f-fdg-pet-in-lung-cancer-43288https://curecurrent.com/trials/expanded-access-to-telisotuzumab-vedotin-43289https://curecurrent.com/trials/neoadjuvant-therapy-of-sbrt-sequencial-with-toripalimab-and-chemotherapy-in-resectable-stage-ii-iii-nsclc-patients-neor-43290https://curecurrent.com/trials/a-phase-clinical-study-of-sys6010-in-combination-with-osimertinib-in-patients-with-locally-advanced-or-metastatic-nsclc-43291https://curecurrent.com/trials/skb264-combinatiton-therapy-in-patients-with-advanced-or-metastatic-non-small-cell-lung-cancer-43292https://curecurrent.com/trials/a-study-of-multiple-immunotherapy-based-treatment-combinations-in-participants-with-metastatic-non-small-cell-lung-cance-43293https://curecurrent.com/trials/imp3-sarna-vaccine-in-advanced-nsclc-43294https://curecurrent.com/trials/advancing-precision-lung-cancer-surveillance-and-outcomes-in-diverse-populations-43295https://curecurrent.com/trials/efficacy-and-safety-of-radiotherapy-compared-to-everolimus-in-somatostatin-receptor-positive-neuroendocrine-tumors-of-th-43296https://curecurrent.com/trials/a-study-evaluating-platinum-pemetrexed-atezolizumab-bevacizumab-for-patients-with-stage-iiib-iv-non-squamous-non-small-c-43297https://curecurrent.com/trials/a-phase-ii-study-of-skb571-in-patients-with-lung-cancer-43298https://curecurrent.com/trials/ningetinib-ct053ptsa-plus-gefitinib-in-stage-iiib-or-iv-nsclc-patients-with-egfr-mutation-and-t790m-negative-43299https://curecurrent.com/trials/a-study-of-novel-anti-cancer-agents-in-patients-with-previously-untreated-nsclc-43300https://curecurrent.com/trials/emulation-of-the-keynote-042-nct02220894-trial-using-specialty-oncology-electronic-health-records-databases-43301https://curecurrent.com/trials/targeted-therapy-with-cdk4-6-inhibitors-in-chemo-refractory-rb-wild-type-extensive-sclc-43302https://curecurrent.com/trials/effect-of-cyp2d6-10-gene-mutation-on-perioperative-precision-analgesia-of-oxycodone-in-elderly-patients-43303https://curecurrent.com/trials/dotatoc-pet-ct-for-imaging-net-patients-43304https://curecurrent.com/trials/combination-study-of-guadecitabine-astx727-and-pembrolizumab-43305https://curecurrent.com/trials/molecular-profiling-project-43306https://curecurrent.com/trials/a-study-of-ociperlimab-with-tislelizumab-compared-to-pembrolizumab-in-participants-with-untreated-lung-cancer-43307https://curecurrent.com/trials/treating-early-stage-non-small-cell-lung-cancer-with-durvalumab-and-radiation-therapy-43308https://curecurrent.com/trials/deep-learning-using-chest-x-rays-to-identify-high-risk-patients-for-lung-cancer-screening-ct-43309https://curecurrent.com/trials/shared-decision-making-on-radiation-dose-for-lung-malignancies-43310https://curecurrent.com/trials/multilevel-intervention-for-ldct-lung-cancer-screening-and-smoking-cessation-among-african-americans-43311https://curecurrent.com/trials/safety-and-tolerability-of-low-dose-radiotherapy-concurrent-sbrt-and-pd-1-inhibitors-in-advanced-nsclc-43312https://curecurrent.com/trials/efficacy-and-safety-evaluation-of-sintilimab-in-patients-with-advanced-or-metastatic-non-squamous-nsclc-43313https://curecurrent.com/trials/a-study-of-skb518-in-patients-with-lung-cancer-43314https://curecurrent.com/trials/effect-of-perioperative-use-of-glycopyrrolate-on-lung-function-in-patients-under-general-anesthesia-43315https://curecurrent.com/trials/a-study-measuring-markers-of-airway-inflammation-in-breath-samples-from-people-with-respiratory-diseases-and-healthy-vol-43316https://curecurrent.com/trials/sunvozertinib-combined-with-chemotherapy-for-egfrm-after-egfr-tki-treatment-failure-phase-i-ii-43317https://curecurrent.com/trials/lung-cancer-biomarkers-and-screening-43318https://curecurrent.com/trials/a-phase-ib-ii-study-of-alectinib-combined-with-cobimetinib-in-advanced-alk-rearranged-alk-nsclc-43319https://curecurrent.com/trials/enhancing-lung-cancer-screening-through-human-centered-intervention-43320https://curecurrent.com/trials/pembrolizumab-in-treating-patients-with-malignant-mesothelioma-43321https://curecurrent.com/trials/adherence-to-lung-cancer-screening-by-low-dose-thoracic-ct-in-haut-rhin-department-france-43322https://curecurrent.com/trials/early-pulmonary-dysfunction-in-childhood-cancer-patients-43323https://curecurrent.com/trials/testing-the-addition-of-activity-monitoring-with-a-wearable-electronic-device-to-improve-patient-care-during-treatment-f-43324https://curecurrent.com/trials/a-study-of-skb264-in-combination-with-pembrolizumab-versus-pembrolizumab-in-patients-with-locally-advanced-or-metastatic-43325https://curecurrent.com/trials/skb500-combinations-in-patients-with-small-cell-lung-cancer-43326https://curecurrent.com/trials/emulation-of-the-checkmate-017-057-nct01642004-and-nct01673867-trials-using-specialty-oncology-electronic-health-records-43327https://curecurrent.com/trials/safety-and-efficacy-of-whole-brain-ldrt-ici-intrathecal-chemotherapy-in-refractory-meningeal-metastasis-of-lung-cancer-43328https://curecurrent.com/trials/nicotine-replacement-therapy-prescribing-and-lung-cancer-screening-in-hospitalized-patients-43329https://curecurrent.com/trials/low-dose-radiotherapy-combined-with-durvalumab-chemotherapy-ep-in-the-treatment-of-es-sclc-43330https://curecurrent.com/trials/clinical-effects-of-alpha-lipoic-acid-in-advanced-nsclc-43331https://curecurrent.com/trials/a-phase-iii-study-of-skb264-for-egfr-mutant-nsclc-patients-43332https://curecurrent.com/trials/pathways-a-hope-intervention-to-support-personal-goal-pursuit-mental-health-and-quality-of-life-during-advanced-lung-can-43333https://curecurrent.com/trials/a-study-to-learn-about-the-study-medicine-called-pf-08046032-in-people-with-advanced-cancers-43334https://curecurrent.com/trials/phase-2-study-for-the-patient-who-has-diagnosed-with-small-cell-lung-cancer-sclc-or-non-small-cell-lung-cancer-nsclc-or-43335https://curecurrent.com/trials/a-study-of-kl590586-in-patients-with-advanced-solid-tumors-43336https://curecurrent.com/trials/a-study-of-targeted-radiation-therapy-in-people-with-non-small-cell-lung-cancer-nsclc-43337https://curecurrent.com/trials/effect-and-long-term-outcomes-of-indocyanine-green-fluorescence-imaging-method-versus-modified-inflation-deflation-metho-43338https://curecurrent.com/trials/3d-us-construct-on-volumetric-assessment-of-lung-disease-clinical-application-43339https://curecurrent.com/trials/universal-car-t-cells-revo-uwd-03-for-advanced-hepatocellular-carcinoma-and-lung-cancer-43340https://curecurrent.com/trials/study-of-sacituzumab-govitecan-sg-versus-docetaxel-in-participants-with-advanced-or-metastatic-non-small-cell-lung-cance-43341https://curecurrent.com/trials/apple-vision-pro-assisted-vascular-identification-in-lung-surgery-43342https://curecurrent.com/trials/ali-post-radiation-therapy-in-patients-with-lung-and-esophageal-canter-43343https://curecurrent.com/trials/study-to-evaluate-adverse-events-change-in-disease-activity-and-how-abbv-706-moves-through-the-body-when-intravenously-i-43344https://curecurrent.com/trials/multidisciplinary-treatment-of-stage-iii-alk-nsclc-with-neoadjuvant-alectinib-and-chemotherapy-43345https://curecurrent.com/trials/early-versus-delayed-rehabilitation-intervention-in-patients-with-lung-cancer-43346https://curecurrent.com/trials/testing-crizotinib-as-a-potential-targeted-treatment-in-cancers-with-alk-genetic-changes-match-subprotocol-f-43347https://curecurrent.com/trials/a-study-to-develop-a-strategy-to-increase-lung-cancer-screening-in-women-who-may-be-at-risk-for-lung-cancer-43348https://curecurrent.com/trials/defining-the-severe-paediatric-asthma-endotype-43349https://curecurrent.com/trials/development-and-preliminary-validation-of-a-perioperative-pulmonary-rehabilitation-nursing-system-for-patients-with-cran-43350https://curecurrent.com/trials/a-study-to-compare-abp-234-and-keytruda-pembrolizumab-in-participants-with-advanced-or-metastatic-non-squamous-non-small-43351https://curecurrent.com/trials/targeted-treatment-for-advanced-non-small-cell-lung-cancer-that-has-increased-copies-of-the-met-gene-an-expanded-lung-ma-43352https://curecurrent.com/trials/rehabilitation-by-effort-for-patients-with-advanced-bronchial-cancer-43353https://curecurrent.com/trials/concomitant-use-of-radiotherapy-and-integrated-exercise-lung-cancer-43354https://curecurrent.com/trials/environment-and-lung-cancer-43355https://curecurrent.com/trials/compairing-r-icnb-and-c-icnb-for-postoperative-pain-management-after-minimal-invasive-anatomical-lung-resection-43356https://curecurrent.com/trials/respiratory-motion-corrected-cone-beam-ct-and-intratreatment-gating-based-on-electromagnetic-transponders-to-reduce-targ-43357https://curecurrent.com/trials/a-study-of-intensity-modulated-pleural-radiation-therapy-imprint-in-people-with-thymic-cancer-that-has-spread-to-the-lin-43358https://curecurrent.com/trials/stereotactic-ablative-radiotherapy-for-oligometastatic-non-small-cell-lung-cancer-43359https://curecurrent.com/trials/a-trial-to-learn-how-the-cancer-vaccine-bnt116-in-combination-with-cemiplimab-works-and-how-safe-the-combination-is-in-a-43360https://curecurrent.com/trials/a-study-evaluating-neoadjuvant-chemoimmunotherapy-with-immunosensitizing-radiation-for-borderline-resectable-non-small-c-43361https://curecurrent.com/trials/using-e-nose-technology-to-identify-early-lung-cancer-43362https://curecurrent.com/trials/wtc-chest-ct-imaging-archive-43363https://curecurrent.com/trials/analysis-of-the-effectiveness-and-safety-of-lorlatinib-in-untreated-alk-positive-nsclc-patients-in-a-french-real-world-c-43364https://curecurrent.com/trials/4d-mri-for-precision-medicine-43365https://curecurrent.com/trials/early-detection-of-lung-cancer-43366https://curecurrent.com/trials/targeted-treatment-for-advanced-non-small-cell-lung-cancer-that-has-a-met-exon-14-skipping-gene-change-an-expanded-lung-43367https://curecurrent.com/trials/a-study-of-pf-08046052-sgn-egfrd2-in-advanced-solid-tumors-43368https://curecurrent.com/trials/study-for-evaluating-the-safety-and-feasibility-of-fecal-microbiota-transplant-in-stage-ii-iii-nsclc-patients-using-ici-43369https://curecurrent.com/trials/adjuvant-pembrolizumab-vs-observation-following-curative-resection-for-stage-i-non-small-cell-lung-cancer-nsclc-with-pri-43370https://curecurrent.com/trials/durvalumab-and-stereotactic-radiotherapy-for-advanced-nsclc-43371https://curecurrent.com/trials/apricity-care-to-improve-ici-outcomes-of-ethnic-racial-minority-nsclc-patients-43372https://curecurrent.com/trials/olanzapine-impact-on-first-line-immunotherapy-for-advanced-egfr-negative-nsclc-43373https://curecurrent.com/trials/adebrelimab-or-retlirafusp-alfa-plus-recaticimab-and-chemotherapy-for-resectable-nsclc-43374https://curecurrent.com/trials/adding-the-immunotherapy-drug-cemiplimab-to-usual-treatment-for-people-with-advanced-non-small-cell-lung-cancer-who-had-43375https://curecurrent.com/trials/nivolumab-and-ipilimumab-plus-chemotherapy-for-patients-with-stage-iv-lung-cancer-with-brain-metastases-43376https://curecurrent.com/trials/safety-and-efficacy-of-radiotherapy-combined-with-immunochemotherapy-in-pre-treated-sclc-patients-with-liver-metastases-43377https://curecurrent.com/trials/stage-iv-lung-squamous-cell-carcinoma-treated-with-or-without-bronchial-artery-chemoembolization-after-first-line-chemot-43378https://curecurrent.com/trials/safety-and-tolerability-of-ldrt-sugemalimab-chemotherapy-olaparib-for-first-line-treatment-of-slfn-11-positive-es-sclc-43379https://curecurrent.com/trials/increasing-lung-cancer-screening-among-emergency-department-patients-lcs-r01-43380https://curecurrent.com/trials/rapid-autopsy-and-procurement-of-cancer-tissue-43381https://curecurrent.com/trials/lorlatinib-plus-local-consolidation-therapy-in-alk-positive-advanced-non-small-cell-lung-cancer-43382https://curecurrent.com/trials/new-adjuvant-trial-of-chemotherapy-vs-chemo-immunotherapy-43383https://curecurrent.com/trials/a-study-to-compare-the-pharmacokinetics-efficacy-safety-and-immunogenicity-of-pembrolizumab-sb27-eu-sourced-keytruda-and-43384https://curecurrent.com/trials/a-randomized-pilot-study-of-evolocumab-plus-nivolumab-ipilimumab-in-treatment-na-ve-patients-with-metastatic-nsclc-43385https://curecurrent.com/trials/benefit-of-cone-beam-ct-and-robotic-assisted-bronchoscopy-during-bronchoscopy-43386https://curecurrent.com/trials/dumas-neo-adjuvant-immunotherapy-for-pancoast-tumors-43387https://curecurrent.com/trials/a-pilot-study-of-single-fraction-stereotactic-body-radiation-therapy-sbrt-in-central-non-small-cell-lung-cancer-43388https://curecurrent.com/trials/study-of-non-small-cell-lung-cancer-patients-in-the-us-receiving-standard-of-care-and-initiating-an-approved-therapy-wit-43389https://curecurrent.com/trials/machine-learning-approaches-to-personalized-therapy-for-advanced-non-small-cell-lung-cancer-with-real-world-data-43390https://curecurrent.com/trials/a-phase-ii-clinical-trial-to-evaluate-safety-and-efficacy-of-xmab20717-in-advanced-rare-cancers-43391https://curecurrent.com/trials/deciphering-antitumour-response-and-resistance-with-intratumour-heterogeneity-43392https://curecurrent.com/trials/feasibility-of-evaluating-gene-alteration-analysis-using-samples-obtained-by-ebus-tbna-in-patients-with-lung-cancer-43393https://curecurrent.com/trials/tracking-non-small-cell-lung-cancer-evolution-through-therapy-rx-43394https://curecurrent.com/trials/increasing-lung-cancer-screening-uptake-among-emergency-department-patients-43395https://curecurrent.com/trials/a-study-of-lp-300-with-carboplatin-and-pemetrexed-in-never-smokers-with-advanced-lung-adenocarcinoma-43396https://curecurrent.com/trials/a-study-of-tiragolumab-in-combination-with-atezolizumab-in-chemotherapy-na-ve-patients-with-locally-advanced-or-metastat-43397https://curecurrent.com/trials/association-between-circulating-immune-cells-and-the-tumor-immune-contexture-in-resectable-non-small-cell-lung-cancer-43398https://curecurrent.com/trials/debio-0123-in-combination-with-carboplatin-and-etoposide-in-adult-participants-with-small-cell-lung-cancer-that-recurred-43399https://curecurrent.com/trials/endobronchial-ultrasound-guided-transbronchial-needle-aspiration-for-lymph-node-staging-in-patients-with-non-small-cell-43400https://curecurrent.com/trials/a-2-part-phase-1-2-open-label-trial-on-odm-212-43401https://curecurrent.com/trials/septum-guided-segmentectomy-for-deep-early-stage-lung-cancer-sgs2512-43402https://curecurrent.com/trials/establishment-of-a-prospective-clinical-cohort-of-small-cell-lung-cancer-patients-receiving-radiotherapy-involved-compre-43403https://curecurrent.com/trials/cone-beam-ct-guided-microcoil-localization-of-pulmonary-nodules-during-video-assisted-thoracic-surgery-vats-43404https://curecurrent.com/trials/ensartinib-in-combination-with-bevacizumab-in-alk-positive-nsclc-patients-with-tp53-mutation-43405https://curecurrent.com/trials/this-study-is-an-open-lable-early-study-to-evaluate-the-safety-feasibility-cytokinetics-and-preliminary-efficacy-of-gc51-43406https://curecurrent.com/trials/phase-ii-study-investigating-the-combination-of-encorafenib-and-binimetinib-in-braf-v600e-mutated-chinese-patients-with-43407https://curecurrent.com/trials/177lu-pp-f11n-for-receptor-targeted-therapy-and-imaging-of-metastatic-thyroid-cancer-43408https://curecurrent.com/trials/multidimensional-omics-analysis-in-malignant-pleural-mesothelioma-43409https://curecurrent.com/trials/effect-of-high-flow-nasal-cannula-oxygen-therapy-on-hypoxemia-in-pediatric-sedated-bronchoscopy-43410https://curecurrent.com/trials/tislelizumab-plus-chemotherapy-and-bace-for-unresectable-nsclc-43411https://curecurrent.com/trials/metabolic-biomarkers-in-thoracic-cancers-43412https://curecurrent.com/trials/one-fraction-simulation-free-treatment-with-ct-guided-stereotactic-adaptive-radiotherapy-for-patients-with-oligometastat-43413https://curecurrent.com/trials/a-study-of-vebreltinib-and-platinum-containing-double-agents-in-subjects-with-met-positive-43414https://curecurrent.com/trials/adebrelimab-combined-with-chemoradiotherapy-in-patients-with-large-bulky-stage-iii-unresectable-non-small-cell-lung-canc-43415https://curecurrent.com/trials/tumor-cell-and-dna-detection-in-the-blood-urine-and-bone-marrow-of-patients-with-solid-cancers-43416https://curecurrent.com/trials/feasibility-and-effectiveness-of-respiratory-movement-management-in-lung-cancer-receiving-stereotactic-radiotherapy-usin-43417https://curecurrent.com/trials/ex-vivo-cof-study-for-lung-cancer-observation-43418https://curecurrent.com/trials/observational-multicenter-study-in-patients-receiving-chemotherapy-and-amivantamab-for-metastatic-non-small-cell-lung-ca-43419https://curecurrent.com/trials/nutritional-assessment-of-patients-with-non-small-cell-lung-cancer-treated-with-osimertinib-43420https://curecurrent.com/trials/development-and-application-of-a-thrombosis-risk-prediction-model-in-lung-cancer-patients-treated-with-immune-checkpoint-43421https://curecurrent.com/trials/trimpact-real-world-first-line-atezolizumab-use-in-stage-iv-nsclc-with-pd-l1-50-43422https://curecurrent.com/trials/atatch-alternating-treatment-plans-for-advanced-cancer-43423https://curecurrent.com/trials/clinical-trial-of-amg510-in-stage-iii-unresectable-nsclc-kras-p-g12c-patients-and-ineligible-for-chemo-radiotherapy-43424https://curecurrent.com/trials/phase-1-2-study-of-x-396-an-oral-alk-inhibitor-in-patients-with-alk-positive-non-small-cell-lung-cancer-43425https://curecurrent.com/trials/shared-decision-making-in-patients-with-lung-cancer-43426https://curecurrent.com/trials/phase-ia-ib-study-of-fxb0871-monotherapy-in-locally-advanced-metastatic-solid-tumors-43427https://curecurrent.com/trials/predictive-value-of-ariscat-index-in-the-development-of-pulmonary-complication-after-major-abdominal-cancer-surgery-43428https://curecurrent.com/trials/neoadjuvant-sbrt-followed-by-sintilimab-plus-chemotherapy-for-n3-positive-nsclc-43429https://curecurrent.com/trials/study-of-pembrolizumab-lenvatinib-and-chemotherapy-combination-in-first-line-extensive-stage-small-cell-lung-cancer-43430https://curecurrent.com/trials/osimertinib-to-suppress-the-progression-of-ggn-egfr-mutation-positive-43431https://curecurrent.com/trials/plinabulin-in-combination-with-radiation-immunotherapy-in-patients-with-select-advanced-cancers-after-progression-on-pd-43432https://curecurrent.com/trials/exploration-of-the-application-of-methotrexate-loaded-drug-vesicles-in-intrathecal-injection-for-meningeal-metastasis-of-43433https://curecurrent.com/trials/nadim-ii-neo-adjuvant-immunotherapy-43434https://curecurrent.com/trials/monalizumab-in-combination-with-durvalumab-medi4736-for-trreatment-of-small-cell-lung-cancer-43435https://curecurrent.com/trials/standard-follow-up-program-sfp-for-lung-cancer-patients-treated-with-radiotherapy-or-chemoradiation-43436https://curecurrent.com/trials/molecular-analysis-of-endoscopic-cytology-samples-supernatant-in-pulmonary-nodules-43437https://curecurrent.com/trials/spatially-fractionated-radiotherapy-combined-with-immunotherapy-for-advanced-solid-tumors-43438https://curecurrent.com/trials/study-of-low-dose-radiotherapy-concurrent-chemotherapy-with-serplulimab-for-patients-with-es-sclc-43439https://curecurrent.com/trials/low-dose-radiotherapy-combined-with-concurrent-chemotherapy-toripalimab-and-tifcemalimab-in-the-treatment-of-es-sclc-43440https://curecurrent.com/trials/vebreltinib-plus-chemotherapy-as-first-line-treatment-for-met-overexpressing-nsclc-43441https://curecurrent.com/trials/recombinant-ephb4-hsa-fusion-protein-with-standard-chemotherapy-regimens-in-treating-patients-with-advanced-or-metastati-43442https://curecurrent.com/trials/osimertinib-in-egfr-mutant-lung-cancer-43443https://curecurrent.com/trials/osimertinib-and-gefitinib-in-egfr-inhibitor-na-ve-advanced-egfr-mutant-lung-cancer-43444https://curecurrent.com/trials/mechanisms-of-resistance-to-amivantamab-in-patients-with-nsclc-with-egfr-exon-20-insertion-43445https://curecurrent.com/trials/analysis-of-biological-characteristics-of-advanced-alk-rearranged-nsclc-43446https://curecurrent.com/trials/neoadjuvant-almonertinib-followed-by-chemo-immunotherapy-in-ii-iiib-egfr-mutant-nsclc-43447https://curecurrent.com/trials/third-generation-egfr-tki-treatment-in-metastatic-egfr-mutant-nsclc-43448https://curecurrent.com/trials/trial-for-local-ablative-treatment-lat-optimization-in-patients-with-advanced-non-small-cells-lung-cancer-nsclc-presenti-43449https://curecurrent.com/trials/study-evaluating-tarlatamab-after-chemoradiotherapy-in-limited-stage-small-cell-lung-cancer-ls-sclc-43450https://curecurrent.com/trials/prospective-master-protocol-for-evaluation-of-systemic-therapeutics-in-elderly-with-thoracic-malignancies-43451https://curecurrent.com/trials/testing-the-safety-of-m6620-vx-970-when-given-with-standard-whole-brain-radiation-therapy-for-the-treatment-of-brain-met-43452https://curecurrent.com/trials/iparomlimab-and-tuvonralimab-injection-combined-with-sbrt-in-patients-with-early-stage-non-small-cell-lung-cancer-43453https://curecurrent.com/trials/phase-1b-2-study-of-ldrt-in-combination-with-ak104-plus-chemotherapy-as-first-line-treatment-for-es-sclc-43454https://curecurrent.com/trials/carboplatin-cisplatin-etoposide-benmelstobart-sequential-benmelstobart-combined-with-anlotinib-versus-carboplatin-cispla-43455https://curecurrent.com/trials/osimertinib-to-suppress-the-progression-of-remaining-ggn-for-egfr-mutation-positive-stage-ib-iiia-lung-adenocarcinoma-43456https://curecurrent.com/trials/study-of-zg006-in-combination-with-pd-1-pd-l1-immune-checkpoint-inhibitors-as-first-line-standard-therapy-in-participant-43457https://curecurrent.com/trials/individualized-treatment-based-on-epidermal-growth-factor-receptor-mutations-and-level-of-brca1-expression-in-advanced-a-43458https://curecurrent.com/trials/gfh375-monotherapy-and-combination-therapy-as-first-line-treatment-for-advanced-kras-g12d-mutant-non-small-cell-lung-can-43459https://curecurrent.com/trials/study-to-evaluate-sutetinib-maleate-capsule-in-locally-advanced-or-metastatic-non-small-cell-lung-cancer-43460https://curecurrent.com/trials/margin-intraoperative-ct-feedback-feedback-study-43461https://curecurrent.com/trials/robotic-assisted-bronchoscopy-guided-synchronous-biopsy-and-radiofrequency-ablation-for-pulmonary-nodules-43462https://curecurrent.com/trials/national-lung-matrix-trial-multi-drug-phase-ii-trial-in-non-small-cell-lung-cancer-43463https://curecurrent.com/trials/promoting-lung-cancer-screening-awareness-and-implementation-in-hispanics-latinx-head-and-neck-cancer-survivors-43464https://curecurrent.com/trials/hec169096-in-participants-with-advanced-solid-tumors-43465https://curecurrent.com/trials/flt3-ligand-immunotherapy-and-stereotactic-radiotherapy-for-advanced-non-small-cell-lung-cancer-43466https://curecurrent.com/trials/delayed-systemic-therapy-following-destructive-local-treatment-of-pulmonary-oligometastases-after-no-evidence-of-disease-43467https://curecurrent.com/trials/bispecific-t-cell-engager-tarlatamab-and-trop2-targeted-antibody-drug-conjugate-sacituzumab-govitecan-in-previously-trea-43468https://curecurrent.com/trials/impact-of-the-coronavirus-covid-19-on-patients-with-cancer-43469https://curecurrent.com/trials/smarca4-2-inhibitor-for-pou2f3-positive-sclc-43470https://curecurrent.com/trials/molecular-predictors-of-cancer-in-patients-at-high-risk-of-lung-cancer-43471https://curecurrent.com/trials/exercise-as-maintenance-therapy-in-advanced-lung-cancer-43472https://curecurrent.com/trials/long-terms-responders-in-metastatic-lung-cancer-better-understanding-for-better-management-lungevity-study-43473https://curecurrent.com/trials/gt201-injection-in-combination-with-teraplizumab-injection-for-treatment-of-patients-with-non-small-cell-lung-cancer-43474https://curecurrent.com/trials/multimodal-ct-based-risk-stratification-for-postoperative-local-recurrence-in-nsclc-a-multicenter-study-43475https://curecurrent.com/trials/perioperative-immunotherapy-for-nsclc-ectop-1030-43476https://curecurrent.com/trials/immunotherapy-or-targeted-therapy-with-or-without-stereotactic-radiosurgery-for-patients-with-brain-metastases-from-mela-43477https://curecurrent.com/trials/well-being-in-cancer-patients-with-neuropathy-during-covid-19-who-participated-in-prior-clinical-trials-43478https://curecurrent.com/trials/autologous-tumor-infiltrating-lymphocyte-injection-gt201-for-treatment-of-patients-with-advanced-lung-cancer-43479https://curecurrent.com/trials/a-first-in-human-study-of-ckd-703-in-advanced-solid-tumors-and-non-small-cell-lung-cancer-43480https://curecurrent.com/trials/relatrilfa-plus-single-agent-chemotherapy-as-neoadjuvant-therapy-for-resectable-stage-ii-iii-nsclc-phase-2-43481https://curecurrent.com/trials/a-study-of-tsn1611-treating-patients-with-advanced-solid-tumors-harboring-kras-g12d-mutation-43482https://curecurrent.com/trials/osa-in-never-smokers-with-lung-cancer-43483https://curecurrent.com/trials/safety-and-preliminary-efficacy-of-pumitamig-bnt327-an-investigational-therapy-for-patients-with-non-small-cell-lung-can-43484https://curecurrent.com/trials/tislelizumab-combined-with-chemotherapy-and-thoracic-radiotherapy-in-es-sclc-43485https://curecurrent.com/trials/a-clinical-study-for-the-safety-and-efficacy-of-bl0020-injection-in-combination-with-toripalimab-injection-in-patients-w-43486https://curecurrent.com/trials/potent-tepotinib-in-combination-with-pembrolizumab-in-nsclc-43487https://curecurrent.com/trials/rural-illinois-lung-cancer-screening-initiative-43488https://curecurrent.com/trials/sleeve-lobectomy-for-lung-cancer-in-minimally-invasive-surgical-techniques-43489https://curecurrent.com/trials/circulating-tumor-cells-ctc-in-lung-cancer-43490https://curecurrent.com/trials/real-world-registry-for-use-of-the-ion-endoluminal-system-43491https://curecurrent.com/trials/comprehensive-oncogenomic-mapping-and-exploration-in-thoracic-and-head-neck-oncology-43492https://curecurrent.com/trials/study-of-225ac-abd147-to-establish-optimal-dose-in-patients-with-sclc-and-lcnec-of-the-lung-that-previously-received-pla-43493https://curecurrent.com/trials/whole-genomic-landscape-of-advanced-egfr-mutant-nsclc-43494https://curecurrent.com/trials/serplulimab-combined-with-chemotherapy-in-patients-with-resectable-non-small-cell-lung-cancer-43495https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-sutetinib-maleate-capsule-in-locally-advanced-or-metastatic-nsclc-43496https://curecurrent.com/trials/zorifertinib-plus-intra-ommaya-csf-chemotherapy-for-leptomeningeal-progression-in-nsclc-after-third-generation-egfr-tki-43497https://curecurrent.com/trials/pembrolizumab-and-palliative-radiotherapy-in-lung-43498https://curecurrent.com/trials/bevacizumab-plus-nab-paclitaxel-and-platinum-for-immunotherapy-treated-non-squamous-non-small-cell-lung-cancer-43499https://curecurrent.com/trials/a-phase-ii-study-of-sacituzumab-tirumotecan-in-combination-with-furmonertinib-in-patients-with-non-squamous-non-small-ce-43500https://curecurrent.com/trials/a-lay-navigation-intervention-for-patients-with-lung-cancer-43501https://curecurrent.com/trials/efficacy-and-safety-evaluation-of-plb1004-in-patients-with-non-squamous-nsclc-harboring-egfr-exon-20-insertion-43502https://curecurrent.com/trials/early-lung-cancer-diagnosis-in-hiv-infected-population-with-an-important-smoking-history-with-low-dose-ct-a-pilot-study-43503https://curecurrent.com/trials/a-clinical-trial-of-pf-08046037-alone-or-with-sasanlimab-in-patients-with-advanced-or-metastatic-malignancies-43504https://curecurrent.com/trials/autologous-tumor-infiltrating-lymphocyte-gte-001-injection-for-treatment-of-patients-with-advanced-lung-adenocarcinoma-43505https://curecurrent.com/trials/osimertinib-plus-savolitinib-in-egfrm-met-nsclc-following-prior-osimertinib-43506https://curecurrent.com/trials/trial-of-a-personalized-and-adaptive-neoantigen-dose-adjusted-vaccine-concurrently-with-pembrolizumab-43507https://curecurrent.com/trials/a-study-evaluating-the-safety-and-efficacy-of-prv111-prv211-and-prv131-in-subjects-with-oral-and-lung-cancers-43508https://curecurrent.com/trials/home-treatment-of-patients-with-active-cancer-and-acute-pulmonary-embolism-without-hestia-criteria-43509https://curecurrent.com/trials/durvalumab-maintenance-after-thoracic-chemoradiotherapy-in-frail-small-cell-lung-cancer-patients-whose-disease-is-limite-43510https://curecurrent.com/trials/double-dose-third-generation-egfr-tki-plus-bevacizumab-and-intrathecal-chemotherapy-for-refractory-leptomeningeal-metast-43511https://curecurrent.com/trials/targeted-treatment-for-alk-positive-patients-who-have-previously-been-treated-for-non-squamous-non-small-cell-lung-cance-43512https://curecurrent.com/trials/ctdna-mrd-guided-consolidation-toripalimab-in-stage-ib-iiia-nsclc-43513https://curecurrent.com/trials/stereotactic-radiosurgery-in-treating-patients-undergoing-chemotherapy-and-radiation-therapy-for-stage-iii-non-small-cel-43514https://curecurrent.com/trials/nab-paclitaxel-combined-with-local-therapy-in-relapsed-sclc-43515https://curecurrent.com/trials/effect-of-ultrasound-guided-erector-spinae-plane-block-on-postoperative-pain-and-sleep-quality-of-infants-with-congenita-43516https://curecurrent.com/trials/patient-reported-outcomes-following-chemoradiotherapy-for-locally-advanced-non-small-cell-lung-cancer-43517https://curecurrent.com/trials/combination-study-with-soluble-lag-3-fusion-protein-eftilagimod-alpha-imp321-and-pembrolizumab-in-patients-with-previous-43518https://curecurrent.com/trials/nsclc-liquid-biopsies-and-exhaled-voc-43519https://curecurrent.com/trials/a-phase-1-2-study-of-vs-7375-in-patients-with-kras-g12d-mutated-solid-tumors-43520https://curecurrent.com/trials/a-phase-1-2-study-of-anvumetostat-in-combination-with-ide397-in-participants-with-advanced-methylthioadenosine-phosphory-43521https://curecurrent.com/trials/efficacy-and-safety-of-skb264-plus-anlotinib-in-egfr-tki-resistant-advanced-nsclc-with-liver-metastasis-43522https://curecurrent.com/trials/phase-iii-open-label-first-line-study-of-dato-dxd-in-combination-with-durvalumab-and-carboplatin-for-advanced-nsclc-with-43523https://curecurrent.com/trials/mri-perfusion-on-t1-and-t2-brain-lesion-s-43524https://curecurrent.com/trials/immune-signature-analysis-of-disease-progression-in-post-immunotherapy-lung-cancer-patients-43525https://curecurrent.com/trials/enhanced-copd-management-in-suspected-lung-cancer-patients-43526https://curecurrent.com/trials/multiparametric-image-analysis-and-correlation-with-outcomes-in-lung-cancer-screening-and-early-stage-lung-cancer-43527https://curecurrent.com/trials/efficacy-safety-of-rad-ifn-administered-with-celecoxib-gemcitabine-in-patients-with-malignant-pleural-mesothelioma-43528https://curecurrent.com/trials/aerosolized-aldesleukin-in-treating-patients-with-lung-metastases-43529https://curecurrent.com/trials/investigation-of-a-smart-probe-for-lung-lesion-characterization-using-impedance-technology-43530https://curecurrent.com/trials/preoperative-radioimmunotherapy-versus-chemoimmunotherapy-in-nsclc-43531https://curecurrent.com/trials/the-impact-of-exercise-on-the-tumor-microenvironment-in-patients-with-lung-cancer-43532https://curecurrent.com/trials/atorvastatin-effect-on-reduction-of-copd-exacerbations-43533https://curecurrent.com/trials/positron-emission-tomography-and-computed-tomography-in-guiding-radiation-therapy-for-stage-iii-non-small-cell-lung-canc-43534https://curecurrent.com/trials/neoadjuvant-ibi308-bevacizumab-plus-pemetrexed-and-carboplatin-followed-by-surgery-in-unresectable-stage-iii-nsclc-43535https://curecurrent.com/trials/a-phase-ii-study-of-atezolizumab-in-combination-with-bevacizumab-carboplatin-or-cisplatin-and-pemetrexed-for-egfr-mutant-43536https://curecurrent.com/trials/pet-avidity-in-cachexia-inducing-lung-and-gastrointestinal-tumors-43537https://curecurrent.com/trials/samotolisib-in-treating-patients-with-relapsed-or-refractory-advanced-solid-tumors-non-hodgkin-lymphoma-or-histiocytic-d-43538https://curecurrent.com/trials/neoadjuvant-umbrella-trial-for-patients-with-unresectable-stage-iii-nsclc-harboring-rare-mutations-43539https://curecurrent.com/trials/rats-sleeve-lobectomy-after-neo-chemo-io-for-nsclc-43540https://curecurrent.com/trials/study-of-itacitinib-in-combination-with-docetaxel-in-subjects-with-non-small-cell-lung-cancer-43541https://curecurrent.com/trials/a-study-to-investigate-the-safety-and-efficacy-of-kqb368-as-monotherapy-in-participants-with-advanced-solid-malignancies-43542https://curecurrent.com/trials/retrospective-review-of-cachexia-in-lung-and-gastrointestinal-cancer-patients-43543https://curecurrent.com/trials/azd9291-versus-gefitinib-or-erlotinib-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-43544https://curecurrent.com/trials/identifying-immune-related-biomarkers-to-predict-the-efficacy-of-cancer-immunotherapy-43545https://curecurrent.com/trials/bronchoscopic-microwave-ablation-of-lung-tissue-in-surgical-candidates-uk-43546https://curecurrent.com/trials/telisotuzumab-vedotin-and-osimertinib-for-the-treatment-of-progressive-incurable-non-small-cell-lung-cancer-43547https://curecurrent.com/trials/metabolomic-characteristics-of-patients-with-non-small-cell-lung-cancer-in-plasma-tissue-and-exhaled-breath-condensate-43548https://curecurrent.com/trials/real-time-imaging-to-improve-lung-cancer-diagnosis-comparing-confocal-laser-endomicroscopy-cle-with-standard-biopsy-for-43549https://curecurrent.com/trials/efficacy-and-safety-of-a-single-dose-of-ls301-it-for-fluorescence-intraoperative-molecular-imaging-imi-for-patients-unde-43550https://curecurrent.com/trials/a-study-of-tucidinostat-combined-with-tislelizumab-as-first-line-treatment-in-advanced-nsclc-43551https://curecurrent.com/trials/anesthesia-and-non-small-cell-lung-cancer-recurrence-43552https://curecurrent.com/trials/a-study-of-atezolizumab-in-combination-with-epacadostat-in-subjects-with-previously-treated-stage-iiib-or-stage-iv-non-s-43553https://curecurrent.com/trials/a-study-of-benmelstobart-anlotinib-chemotherapy-and-thoracic-radiotherapy-for-people-with-extensive-stage-small-cell-lun-43554https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-benfo-oxythiamine-b-ot-in-healthy-volunteers-43555https://curecurrent.com/trials/patient-derived-organoid-model-and-circulating-tumor-cells-for-treatment-response-of-lung-cancer-43556https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-pharmacokinetics-and-safety-of-anecatibin-fumarate-capsules-in-subjects-with-impaired-l-43557https://curecurrent.com/trials/a-trial-of-injectable-shr-a1811-in-combination-with-pyrotinib-or-shr-1316-in-subjects-with-advanced-non-small-cell-lung-43558https://curecurrent.com/trials/evaluate-the-safety-and-efficacy-of-blex-404-oral-liquid-combined-with-pemetrexed-cisplatin-therapy-43559https://curecurrent.com/trials/azd9291-first-time-in-patients-ascending-dose-study-43560https://curecurrent.com/trials/a-study-of-bl-b01d1-in-combination-with-osimertinib-versus-osimertinib-as-first-line-treatment-in-patients-with-egfr-mut-43561https://curecurrent.com/trials/benmelstobart-plus-anlotinib-chemotherapy-and-thoracic-radiation-for-limited-stage-small-cell-lung-cancer-43562https://curecurrent.com/trials/iparomlimab-and-tuvonralimab-plus-chemotherapy-before-surgery-for-stage-iii-lung-cancer-43563https://curecurrent.com/trials/an-initial-experience-with-the-disposable-celsio-cryocatheter-system-for-diagnostic-and-interventional-bronchoscopy-43564https://curecurrent.com/trials/lungs-on-fire-wildfire-smoke-incident-diseases-susceptible-populations-and-community-values-in-canada-43565https://curecurrent.com/trials/study-of-ctx-471-as-a-monotherapy-or-in-combination-with-pembrolizumab-in-patients-post-pd-1-pd-l1-inhibitors-in-metasta-43566https://curecurrent.com/trials/study-of-osimertinib-with-and-without-ramucirumab-in-locally-advanced-or-metastatic-non-small-cell-lung-cancer-nsclc-43567https://curecurrent.com/trials/a-study-comparing-bl-b01d1-with-topotecan-in-patients-with-recurrent-small-cell-lung-cancer-panku-lung03-43568https://curecurrent.com/trials/pathophysiological-mechanisms-involved-in-the-pronostic-and-evolution-of-non-small-cell-lung-cancer-nsclc-at-all-stages-43569https://curecurrent.com/trials/a-study-of-ivonescimab-chemotherapy-and-stereotactic-radiosurgery-for-people-with-non-small-cell-lung-cancer-43570https://curecurrent.com/trials/remission-in-adults-with-severe-asthma-in-thailand-43571https://curecurrent.com/trials/a-phase-1-clinical-trial-of-aur106-in-patients-with-relapsed-advanced-malignancies-43572https://curecurrent.com/trials/a-study-evaluating-the-safety-and-efficacy-of-aur107-in-patients-with-relapsed-advanced-malignancies-shakti-1-43573https://curecurrent.com/trials/a-study-of-bms-986484-alone-and-combination-therapy-in-participants-with-advanced-solid-tumors-43574https://curecurrent.com/trials/a-study-of-an-fgfr2-3-inhibitor-cgt4859-in-patients-with-cholangiocarcinoma-and-other-advanced-solid-tumors-43575https://curecurrent.com/trials/pembrolizumab-as-neoadjuvant-therapy-for-resectable-stage-ia3-to-iia-non-small-cell-lung-cancer-nsclc-43576https://curecurrent.com/trials/lungevity-lung-cancer-stigma-community-based-participatory-research-43577https://curecurrent.com/trials/comprehensive-prospective-comparison-of-two-robotic-platforms-in-anatomical-lung-resections-clinical-outcomes-and-cost-u-43578https://curecurrent.com/trials/a-study-comparing-bl-b01d1-with-docetaxel-in-patients-with-unresectable-locally-advanced-or-metastatic-egfr-wild-type-no-43579https://curecurrent.com/trials/ramucirumab-plus-pembrolizumab-vs-usual-care-for-treatment-of-stage-iv-or-recurrent-non-small-cell-lung-cancer-following-43580https://curecurrent.com/trials/a-study-comparing-abelacimab-to-dalteparin-in-the-treatment-of-gastrointestinal-genitourinary-cancer-and-associated-vte-43581https://curecurrent.com/trials/pembrolizumab-in-preventing-lung-cancer-in-patients-with-stage-i-ii-non-small-cell-lung-cancer-or-high-risk-pulmonary-no-43582https://curecurrent.com/trials/patient-preference-for-subcutaneous-vs-intravenous-immune-therapy-43583https://curecurrent.com/trials/assessment-of-probe-based-confocal-laser-endo-microscopy-for-in-vivo-diagnosis-of-peripheral-lung-nodules-and-masses-43584https://curecurrent.com/trials/osimertinib-in-combination-with-alisertib-or-sapanisertib-for-the-treatment-of-osimertinib-resistant-egfr-mutant-stage-i-43585https://curecurrent.com/trials/tate-and-pembrolizumab-mk3475-in-mcrc-and-nsclc-43586https://curecurrent.com/trials/jolt-ca-sublobar-resection-sr-versus-stereotactic-ablative-radiotherapy-sabr-for-lung-cancer-43587https://curecurrent.com/trials/phase-ii-clinical-study-of-probiotic-lr607-in-patients-with-non-small-cell-lung-cancer-43588https://curecurrent.com/trials/scout-dose-of-resin-microspheres-43589https://curecurrent.com/trials/implementation-of-a-system-level-tobacco-treatment-intervention-43590https://curecurrent.com/trials/the-effect-of-pulmonary-rehabilitation-on-pulmonary-function-tests-exercise-capacity-and-quality-of-life-in-patients-wit-43591https://curecurrent.com/trials/apixaban-in-thrombocytopenia-43592https://curecurrent.com/trials/smoking-cessation-intervention-during-low-dose-ct-ldct-screening-for-lung-cancer-43593https://curecurrent.com/trials/incentive-spirometry-to-improve-outcomes-in-lung-cancer-patients-undergoing-concurrent-chemotherapy-and-radiation-therap-43594https://curecurrent.com/trials/immunotherapy-biomarkers-to-predict-first-line-pd-l-1-based-immunotherapy-response-and-selection-of-second-line-treatmen-43595https://curecurrent.com/trials/itil-306-in-advanced-solid-tumors-43596https://curecurrent.com/trials/reduced-dose-carboplatin-doublet-chemotherapy-cemiplimab-vs-cemiplimab-monotherapy-in-treatment-naive-older-and-frail-pa-43597https://curecurrent.com/trials/clinical-trial-on-safety-and-efficacy-of-thoracoabdominal-endoscopic-surgical-system-for-pediatric-surgery-43598https://curecurrent.com/trials/a-multinational-randomized-open-label-study-of-custirsen-in-patients-with-advanced-or-metastatic-stage-iv-non-small-cell-43599https://curecurrent.com/trials/zelenectide-pevedotin-in-nectin4-amplified-advanced-or-metastatic-non-small-cell-lung-cancer-43600https://curecurrent.com/trials/a-study-of-tislelizumab-in-combination-with-investigational-agents-in-participants-with-non-small-cell-lung-cancer-43601https://curecurrent.com/trials/a-single-arm-trial-of-atezolizumab-platinum-etoposide-for-the-treatment-of-advanced-large-cell-neuroendocrine-cancer-of-43602https://curecurrent.com/trials/real-world-outcomes-of-first-line-nivolumab-ipilimumab-with-chemotherapy-in-non-small-cell-lung-cancer-in-poland-43603https://curecurrent.com/trials/study-of-outcomes-of-radiofrequency-ablation-of-lung-tumors-43604https://curecurrent.com/trials/complications-after-ct-guided-lung-biopsies-at-st-olavs-hospital-43605https://curecurrent.com/trials/trilaciclib-in-patients-receiving-sacituzumab-tirumotecan-for-egfr-mutated-advanced-non-small-cell-lung-cancer-nsclc-43606https://curecurrent.com/trials/downstaging-and-rats-after-neo-chemo-io-impact-on-surgical-outcomes-in-nsclc-43607https://curecurrent.com/trials/microwave-ablation-plus-tislelizumab-and-docetaxel-in-advanced-nsclc-after-first-line-immunotherapy-failure-43608https://curecurrent.com/trials/low-4-vs-physiologic-8-pressure-digital-continuous-suction-after-lung-resection-43609https://curecurrent.com/trials/ablative-stereotactic-radiotherapy-with-durvalumab-medi4736-43610https://curecurrent.com/trials/ug3-pilot-clinical-trial-43611https://curecurrent.com/trials/cilengitide-together-with-radiochemotherapy-in-patients-with-locally-advanced-non-small-cell-lung-cancer-43612https://curecurrent.com/trials/cardiopulmonary-exercise-testing-in-lung-cancer-patients-before-and-during-oncological-treatment-43613https://curecurrent.com/trials/the-effect-of-mindfulness-based-breathing-exercises-on-dyspnea-symptom-control-and-quality-of-life-in-lung-cancer-patien-43614https://curecurrent.com/trials/addition-of-hypofractionated-high-dose-radiation-in-oligometastatic-disease-43615https://curecurrent.com/trials/imfinzi-imjudo-nsclc-japan-pms-japan-post-marketing-surveillance-pms-study-cei-scei-43616https://curecurrent.com/trials/centrally-confined-8gy-1f-to-tumor-core-followed-by-concurrent-chemoradiotherapy-for-unresectable-stage-iii-nsclc-43617https://curecurrent.com/trials/thoracic-radiotherapy-and-inhibition-of-pd-1-and-lag-3-for-locally-advanced-non-small-cell-lung-cancer-43618https://curecurrent.com/trials/efficacy-of-a-self-efficacy-nursing-model-in-cyberknife-treated-lung-cancer-patients-43619https://curecurrent.com/trials/shortened-high-dose-palliative-radiotherapy-for-lung-cancer-43620https://curecurrent.com/trials/study-of-ryz101-in-combination-with-soc-in-subjects-with-sstr-es-sclc-43621https://curecurrent.com/trials/atezolizumab-after-concurrent-chemo-radiotherapy-versus-chemo-radiotherapy-alone-in-limited-disease-small-cell-lung-canc-43622https://curecurrent.com/trials/a-study-of-oral-7hp349-alintegimod-in-combination-with-ipilimumab-followed-by-nivolumab-monotherapy-43623https://curecurrent.com/trials/grid-radiation-therapy-for-the-treatment-of-stage-iv-non-small-cell-lung-cancer-43624https://curecurrent.com/trials/a-study-of-brigatinib-as-preferred-first-therapy-for-adults-with-non-small-cell-lung-cancer-nsclc-entirety-43625https://curecurrent.com/trials/metabolomic-and-epigenetic-profiling-of-bodyfluids-from-lung-and-brain-cancer-receiving-radiation-therapy-43626https://curecurrent.com/trials/patient-generated-health-data-collection-during-chemoradiotherapy-for-lung-cancer-43627https://curecurrent.com/trials/transthoracic-vs-transbronchial-radiofrequency-ablation-for-lung-cancer-43628https://curecurrent.com/trials/electroacupuncture-plus-5-ht3-receptor-inhibitor-for-ponv-prevention-in-high-risk-patients-undergoing-thoracoscopic-lung-43629https://curecurrent.com/trials/lung-cancer-screening-for-early-detection-of-suspicious-lung-nodules-in-latin-america-lucas-latam-43630https://curecurrent.com/trials/intense-a-phase-i-ii-study-of-inhomogeneous-targeted-dose-escalation-in-non-small-cell-lung-cancer-43631https://curecurrent.com/trials/pcsk9-inhibitor-and-pd-1-inhibitor-in-patients-with-metastatic-refractory-to-prior-anti-pd-1-non-small-cell-lung-43632https://curecurrent.com/trials/segmentectomy-versus-lobectomy-for-lung-adenocarcinoma-2cm-43633https://curecurrent.com/trials/real-time-activity-monitoring-to-prevent-admissions-during-radiotherapy-43634https://curecurrent.com/trials/safety-and-tolerability-of-tng456-alone-and-in-combination-with-abemaciclib-in-patients-with-solid-tumors-with-mtap-loss-43635https://curecurrent.com/trials/a-phase-iii-study-comparing-taletrectinib-with-standard-therapy-in-ros1-positive-locally-advanced-or-metastatic-non-smal-43636https://curecurrent.com/trials/risk-of-chemotherapy-toxicity-in-older-patients-with-blood-cancer-or-non-small-cell-lung-cancer-43637https://curecurrent.com/trials/a-simple-walking-program-to-enhance-concurrent-chemoradiotherapy-delivery-43638https://curecurrent.com/trials/lung-cancer-screening-ct-for-firefighters-43639https://curecurrent.com/trials/continuous-activity-monitoring-during-fractionated-radiotherapy-in-patients-with-head-and-neck-lung-or-gastrointestinal-43640https://curecurrent.com/trials/tazemetostat-in-treating-patients-with-relapsed-or-refractory-advanced-solid-tumors-non-hodgkin-lymphoma-or-histiocytic-43641https://curecurrent.com/trials/a-clinical-study-of-tqb3616-capsules-combined-with-anlotinib-hydrochloride-capsules-or-standard-chemotherapy-second-line-43642https://curecurrent.com/trials/sacituzumab-tirumotecan-in-combination-with-anlotinib-in-previously-treated-patients-with-extensive-stage-small-cell-lun-43643https://curecurrent.com/trials/to-explore-the-safety-and-efficacy-of-hypervision-proton-surgery-for-early-stage-non-small-cell-lung-cancer-43644https://curecurrent.com/trials/adapting-and-testing-a-novel-self-compassion-intervention-to-reduce-lung-cancer-stigma-43645https://curecurrent.com/trials/phase-ib-study-of-the-safety-of-t-dxd-and-immunotherapy-agents-with-and-without-chemotherapy-in-advanced-or-metastatic-h-43646https://curecurrent.com/trials/one-stop-diagnosis-and-treatment-for-suspected-lung-cancer-combined-rbs-ncle-obct-and-ablation-43647https://curecurrent.com/trials/glutamine-plus-l-reuteri-prevents-tki-therapy-diarrhea-in-patients-with-nsclc-43648https://curecurrent.com/trials/the-selective-personalized-radio-immunotherapy-for-locally-advanced-nsclc-trial-43649https://curecurrent.com/trials/nitroglycerin-plus-radiotherapy-versus-conventional-radiotherapy-in-patients-with-lung-cancer-43650https://curecurrent.com/trials/study-of-ide397-in-participants-with-solid-tumors-harboring-mtap-deletion-43651https://curecurrent.com/trials/erector-spinae-versus-intercostal-nerve-blocks-with-liposomal-bupivacaine-for-analgesia-in-thoracic-surgery-43652https://curecurrent.com/trials/clinical-investigation-evaluating-the-performance-safety-and-clinical-benefit-of-the-endowave-flexablate-microwave-ablat-43653https://curecurrent.com/trials/a-study-to-compare-efficacy-safety-and-immunogenicity-of-gme751-and-eu-authorized-keytruda-in-adult-participants-with-un-43654https://curecurrent.com/trials/lorlatinib-in-patients-with-alk-positive-nsclc-with-brain-or-leptomeningeal-metastases-43655https://curecurrent.com/trials/metformin-plus-tyrosine-kinase-inhibitors-for-treatment-of-patients-with-non-small-cell-lung-cancer-with-egfr-mutations-43656https://curecurrent.com/trials/ivonescimab-in-combination-with-docetaxel-in-advanced-non-small-cell-lung-cancer-43657https://curecurrent.com/trials/phase-ib-of-l-nmma-and-pembrolizumab-43658https://curecurrent.com/trials/a-study-of-participant-reported-preference-for-subcutaneous-pembrolizumab-coformulated-with-berahyaluronidase-alfa-mk-34-43659https://curecurrent.com/trials/telerehabilitation-in-oncology-patients-43660https://curecurrent.com/trials/simplified-exercise-based-risk-assessment-in-lung-cancer-43661https://curecurrent.com/trials/oscillating-positive-expiratory-pressure-therapy-for-patients-with-thoracic-neoplasms-undergoing-chest-surgery-43662https://curecurrent.com/trials/avecure-flexible-microwave-ablation-probe-for-lung-nodules-43663https://curecurrent.com/trials/anlotinib-plus-durvalumab-platinum-etoposide-in-first-line-treatment-extensive-small-cell-lung-cancer-43664https://curecurrent.com/trials/study-of-collection-and-analysis-of-clinical-anamnestic-functional-biological-data-through-the-support-of-artificial-int-43665https://curecurrent.com/trials/esperanza-external-control-arm-study-for-t-dxd-for-patients-with-her2-ihc3-solid-tumors-43666https://curecurrent.com/trials/clinical-study-of-shr-a1921-combined-with-adebrelimab-and-shr-8068-with-or-without-carboplatin-in-the-treatment-of-advan-43667https://curecurrent.com/trials/combining-furmonertinib-with-local-therapy-for-inoperable-early-stage-lung-cancer-a-phase-ii-trial-43668https://curecurrent.com/trials/pulmonary-rehabilitation-in-advanced-non-small-cell-lung-cancer-patients-43669https://curecurrent.com/trials/osimertinib-induction-and-maintenance-for-chemo-ineligible-stage-iii-unresectable-egfr-nsclc-single-arm-study-43670https://curecurrent.com/trials/delayed-or-upfront-brain-radiotherapy-in-treatment-na-ve-lung-cancer-patients-with-asymptomatic-or-minimally-symptomatic-43671https://curecurrent.com/trials/io102-io103-in-combination-with-pembrolizumab-as-first-line-treatment-for-patients-with-metastatic-nsclc-scchn-or-mubc-43672https://curecurrent.com/trials/temozolomide-and-atezolizumab-for-subsequent-line-for-the-treatment-of-metastatic-or-recurrent-small-cell-lung-cancer-43673https://curecurrent.com/trials/pathogenic-variants-in-genes-associated-with-lung-adenocarcinoma-43674https://curecurrent.com/trials/study-of-inlexisertib-dcc-3116-in-participants-with-ras-mapk-pathway-mutant-solid-tumors-43675https://curecurrent.com/trials/lumbar-punctures-for-the-detection-of-ctdna-in-the-cerebrospinal-fluid-of-patients-with-stage-iii-and-iv-non-small-cell-43676https://curecurrent.com/trials/the-research-plan-of-taiwan-precision-medicine-43677https://curecurrent.com/trials/alectinib-pharmacokinetic-in-patients-with-nsclc-43678https://curecurrent.com/trials/a-phase-ii-clinical-study-of-fh-006-for-injection-combined-with-other-anticancer-therapies-in-subjects-with-lung-cancer-43679https://curecurrent.com/trials/prophylactic-inhaled-steroids-to-reduce-radiation-pneumonitis-frequency-and-severity-in-lung-cancer-patients-43680https://curecurrent.com/trials/adagrasib-srs-for-patients-with-metastatic-kras-g12c-mutated-nsclc-with-untreated-brain-metastases-43681https://curecurrent.com/trials/confocal-laser-endomicroscopy-verification-43682https://curecurrent.com/trials/clinical-effectiveness-and-safety-of-shr-a1811-in-chinese-patients-with-her2-altered-nsclc-43683https://curecurrent.com/trials/fast-tils-to-treat-metastatic-pleural-effusions-from-epithelial-or-mesothelial-primary-tumors-43684https://curecurrent.com/trials/ncle-cone-beam-ct-navigation-bronchoscopy-43685https://curecurrent.com/trials/a-study-of-vet3-tgi-in-patients-with-solid-tumors-43686https://curecurrent.com/trials/galenos-2-immunonutrition-in-head-and-neck-lung-and-rectal-cancer-patients-43687https://curecurrent.com/trials/real-world-evaluation-of-sotorasib-among-chinese-non-small-cell-lung-cancer-patients-43688https://curecurrent.com/trials/lb-100-carboplatin-etoposide-and-atezolizumab-for-the-treatment-of-untreated-extensive-stage-small-cell-lung-cancer-43689https://curecurrent.com/trials/surgery-versus-stereotactic-body-radiation-therapy-for-stage-i-non-small-cell-lung-cancer-43690https://curecurrent.com/trials/neoadjuvant-cemiplimab-for-the-treatment-of-resectable-nsclc-hcc-and-hnscc-in-adult-patients-43691https://curecurrent.com/trials/the-sentinl-1-study-evaluating-patient-reported-outcomes-of-ai-inferred-lung-cancer-risk-43692https://curecurrent.com/trials/modified-short-course-radiotherapy-combined-with-immunochemotherapy-and-targeted-therapy-as-first-line-treatment-for-mss-43693https://curecurrent.com/trials/a-trial-of-chadox1-and-mva-vaccines-against-mage-a3-and-ny-eso-1-43694https://curecurrent.com/trials/dual-target-msln-fap-car-nk-cells-for-pleural-and-peritoneal-mesothelioma-43695https://curecurrent.com/trials/bevacizumab-plus-fsrt-versus-hippocampus-avoidant-wbrt-in-lung-adenocarcinoma-with-extensive-brain-metastases-43696https://curecurrent.com/trials/adaptive-hypofractionated-radiotherapy-for-locally-advanced-nsclc-based-on-dynamic-enhanced-mri-43697https://curecurrent.com/trials/galenos-1-in-head-and-neck-lung-and-rectal-cancer-patients-43698https://curecurrent.com/trials/project-heals-helping-and-empowering-patients-for-living-a-life-smoke-free-43699https://curecurrent.com/trials/nivolumab-with-or-without-ipilimumab-or-chemotherapy-in-treating-patients-with-previously-untreated-stage-i-iiia-non-sma-43700https://curecurrent.com/trials/defactinib-avutometinib-and-nivolumab-for-the-treatment-of-anti-pd1-refractory-lkb1-mutant-advanced-non-small-cell-lung-43701https://curecurrent.com/trials/a-global-study-to-assess-the-effects-of-medi4736-durvalumab-in-patients-with-locally-advanced-or-metastatic-non-small-ce-43702https://curecurrent.com/trials/real-world-association-between-concomitant-beta-blocker-exposure-and-anti-pd-1-pd-l1-treatment-outcomes-in-advanced-non-43703https://curecurrent.com/trials/trial-evaluating-maintenance-olaparib-in-patients-with-platinum-sensitive-advanced-non-small-cell-lung-cancer-43704https://curecurrent.com/trials/a-study-of-atezolizumab-plus-carboplatin-and-etoposide-with-or-without-tiragolumab-in-patients-with-untreated-extensive-43705https://curecurrent.com/trials/study-to-determine-the-safety-and-pharmacokinetics-of-do-2-in-patients-with-advanced-or-refractory-solid-tumours-43706https://curecurrent.com/trials/palbociclib-in-treating-patients-with-relapsed-or-refractory-rb-positive-advanced-solid-tumors-non-hodgkin-lymphoma-or-h-43707https://curecurrent.com/trials/fl-261-imaging-for-cancer-diagnosis-and-staging-43708https://curecurrent.com/trials/real-world-data-on-the-treatment-of-lung-cancer-patients-with-the-immune-checkpoint-inhibitor-tislelizumab-43709https://curecurrent.com/trials/carfilzomib-in-combination-with-sotorasib-for-the-treatment-of-patients-with-kras-g12c-mutated-advanced-or-metastatic-no-43710https://curecurrent.com/trials/efficacy-and-safety-of-sacituzumab-tirumotecan-skb264-in-combination-with-toripalimab-in-patients-with-initially-unresec-43711https://curecurrent.com/trials/a-phase-ii-study-of-benmelstobart-anlotinib-chemotherapy-as-first-line-treatment-for-lcnec-and-ep-nec-43712https://curecurrent.com/trials/oral-pooled-fecal-microbiotherapy-maat033-concomitant-to-cemiplimab-versus-best-investigator-s-choice-in-patients-with-r-43713https://curecurrent.com/trials/a-study-to-investigate-safety-tolerability-pk-and-anti-tumor-activity-of-trx-221-in-egfrm-nsclc-patients-43714https://curecurrent.com/trials/magnetic-resonance-guided-adaptive-stereotactic-body-radiotherapy-for-lung-tumors-in-ultracentral-location-43715https://curecurrent.com/trials/trial-comparing-systemic-therapy-alone-and-with-local-ablative-treatment-for-stage-iv-nscl-cancer-patients-43716https://curecurrent.com/trials/collaborative-clinical-translational-cohort-of-amivantamab-plus-lazertinib-and-amivantamab-plus-chemotherapy-in-patients-43717https://curecurrent.com/trials/multimodality-treatment-in-stage-iii-non-small-cell-lung-cancer-nsclc-43718https://curecurrent.com/trials/pulsatile-high-dose-furmonertinib-in-egfr-mutant-nsclc-with-leptomeningeal-metastasis-43719https://curecurrent.com/trials/durvalumab-and-consolidation-sbrt-following-chemoradiation-for-locally-advanced-stage-iii-non-small-cell-lung-43720https://curecurrent.com/trials/immunonutrition-reduces-acute-esophagitis-after-thoracic-radiotherapy-in-lung-cancer-43721https://curecurrent.com/trials/singing-training-vs-usual-care-6-18-months-after-surgical-resection-for-non-small-cell-lung-cancer-nsclc-43722https://curecurrent.com/trials/a-study-of-tas3351-in-nsclc-patients-with-egfrmt-43723https://curecurrent.com/trials/stereotactic-body-radiation-therapy-followed-by-surgery-in-treating-patients-with-stage-i-iiia-non-small-cell-lung-cance-43724https://curecurrent.com/trials/cadherin-3-cdh3-targeted-pet-in-lung-malignant-tumors-43725https://curecurrent.com/trials/phase-i-ii-study-of-nivolumab-and-ipilimumab-combined-with-nintedanib-in-non-small-cell-lung-cancer-43726https://curecurrent.com/trials/managed-access-programs-for-ldk378-ceritinib-43727https://curecurrent.com/trials/chatbot-and-activity-monitoring-in-patients-undergoing-chemoradiotherapy-43728https://curecurrent.com/trials/pharmacokinetic-similarity-between-abp-234-and-keytruda-pembrolizumab-43729https://curecurrent.com/trials/using-biomarkers-for-diagnosis-risk-stratification-of-post-treatment-recurrence-and-long-term-surveillance-of-lung-cance-43730https://curecurrent.com/trials/neoadjuvant-therapy-with-ensartinib-combined-with-chemotherapy-for-alk-positive-non-small-cell-lung-cancer-nsclc-43731https://curecurrent.com/trials/hippocampus-protective-radiotherapy-combined-with-osimertinib-for-symptomatic-brain-metastases-in-egfr-mutated-lung-canc-43732https://curecurrent.com/trials/tribally-engaged-approaches-to-lung-screening-teals-43733https://curecurrent.com/trials/decamp-1-plus-prediction-of-lung-cancer-using-noninvasive-biomarkers-43734https://curecurrent.com/trials/pembrolizumab-with-or-without-anetumab-ravtansine-in-treating-patients-with-mesothelin-positive-pleural-mesothelioma-43735https://curecurrent.com/trials/radiotherapy-and-durvalumab-durvalumab-combo-tremelimumab-olaparid-for-small-cell-lung-cancer-43736https://curecurrent.com/trials/fap-targeted-pet-nir-in-lung-malignant-tumors-43737https://curecurrent.com/trials/decamp-2-screening-of-patients-with-early-stage-lung-cancer-or-at-high-risk-for-developing-lung-cancer-43738https://curecurrent.com/trials/genomically-guided-radiation-dose-personalization-in-locally-advanced-nsclc-43739https://curecurrent.com/trials/mrx-2843-and-osimertinib-for-the-treatment-of-advanced-egfr-mutant-non-small-cell-lung-cancer-43740https://curecurrent.com/trials/yittrium-90-y-90-fibroblast-activation-protein-inhibitor-fapi-therapy-in-patients-with-non-small-cell-lung-cancer-phase-43741https://curecurrent.com/trials/durvalumab-and-lurbinectedin-for-the-treatment-of-relapsed-or-refractory-small-cell-lung-cancer-43742https://curecurrent.com/trials/contribution-of-the-cest-sequence-in-the-characterization-of-radionecrosis-of-brain-metastases-of-pulmonary-origin-43743https://curecurrent.com/trials/safety-and-efficacy-of-neoantigen-based-personalized-immunotherapy-as-consolidation-therapy-after-standard-adjuvant-trea-43744https://curecurrent.com/trials/dose-escalation-radiotherapy-in-limited-stage-small-cell-lung-cancer-a-phase-iii-randomized-trial-43745https://curecurrent.com/trials/study-of-capmatinib-in-chinese-adult-patients-with-advanced-non-small-cell-lung-cancer-harboring-met-exon-14-skipping-mu-43746https://curecurrent.com/trials/osimertinib-in-treating-participants-with-stage-i-iiia-egfr-mutant-non-small-cell-lung-cancer-before-surgery-43747https://curecurrent.com/trials/kras-targeted-vaccine-with-chemoimmunotherapy-nivolumab-and-ipilimumab-for-patients-with-nsclc-43748https://curecurrent.com/trials/evaluation-of-jskn016-combination-therapy-in-subjects-with-nsclc-43749https://curecurrent.com/trials/crizotinib-continuation-clinical-study-43750https://curecurrent.com/trials/immune-and-genomic-markers-in-alk-nsclc-43751https://curecurrent.com/trials/using-biomarker-tests-to-select-and-test-new-personalized-treatments-for-extensive-stage-small-cell-lung-cancer-prism-st-43752https://curecurrent.com/trials/mdt-based-nursing-for-small-cell-lung-cancer-during-chemo-immunotherapy-43753https://curecurrent.com/trials/feasibility-of-fluorescence-imaging-with-bevacizumab-800cw-during-bronchoscopy-43754https://curecurrent.com/trials/lung-cancer-screening-with-low-dose-ct-scan-in-women-implementation-study-43755https://curecurrent.com/trials/thoracic-surgery-intercostal-block-trial-with-liposomal-vs-hydrochloride-bupivacaine-43756https://curecurrent.com/trials/respiratory-muscle-training-in-patients-undergoing-lung-cancer-surgery-43757https://curecurrent.com/trials/hemithoracic-irradiation-with-proton-therapy-in-malignant-pleural-mesothelioma-43758https://curecurrent.com/trials/fc-engineered-anti-ctla-4-monoclonal-antibody-in-advanced-cancer-43759https://curecurrent.com/trials/the-transitions-project-efficacy-trial-43760https://curecurrent.com/trials/phase-2-study-of-fingolimod-in-lung-cancers-43761https://curecurrent.com/trials/empowering-hispanic-patients-lung-cancer-screening-uptake-empower-latinx-43762https://curecurrent.com/trials/tak-788-as-first-line-treatment-versus-platinum-based-chemotherapy-for-non-small-cell-lung-cancer-nsclc-with-egfr-exon-2-43763https://curecurrent.com/trials/lung-cancer-prevention-screening-programme-in-italy-43764https://curecurrent.com/trials/tils-therapy-for-multiple-primary-early-stage-nsclc-43765https://curecurrent.com/trials/light-dosimetry-for-photodynamic-therapy-with-porfimer-sodium-in-treating-participants-with-malignant-mesothelioma-or-no-43766https://curecurrent.com/trials/post-marketing-surveillance-pms-study-of-lorviqua-in-korea-43767https://curecurrent.com/trials/a-study-to-evaluate-the-tolerability-safety-and-pk-of-ast-201-in-patients-with-gpc3-positive-advanced-solid-tumors-43768https://curecurrent.com/trials/tils-plus-third-generation-egfr-tki-therapy-for-tki-resistant-nsclc-43769https://curecurrent.com/trials/thoracic-radiotherapy-plus-durvalumab-in-elderly-and-or-frail-nsclc-stage-iii-patients-unfit-for-chemotherapy-43770https://curecurrent.com/trials/3d-lung-reconstructions-using-open-source-software-for-lung-cancer-surgery-43771https://curecurrent.com/trials/multicenter-validation-of-the-sensitivity-of-theranostic-alk-rearrangement-detection-by-fish-analysis-and-prevalence-of-43772https://curecurrent.com/trials/the-transitions-project-supporting-adults-during-the-shift-from-cancer-treatment-to-surveillance-43773https://curecurrent.com/trials/study-of-sacituzumab-tirumotecan-combined-with-toripalimab-for-resectable-stage-ii-iiib-nsclc-43774https://curecurrent.com/trials/ai-for-lung-cancer-risk-definition-in-computed-tomography-screening-programs-43775https://curecurrent.com/trials/spontaneous-breathing-mode-a-risk-for-hypoxemia-during-olv-43776https://curecurrent.com/trials/biomarker-platform-virtual-nodule-clinic-for-the-management-of-indeterminate-pulmonary-nodules-43777https://curecurrent.com/trials/phase-1b-trial-of-intratumoral-cisplatin-for-stage-iv-lung-cancer-43778https://curecurrent.com/trials/immune-mechanisms-after-radiofrequency-ablation-of-pulmonary-metastases-from-colorectal-cancer-origin-43779https://curecurrent.com/trials/evidence-based-nursing-plus-progressive-exercise-for-cancer-related-fatigue-in-advanced-lung-cancer-43780https://curecurrent.com/trials/osimertinib-combined-with-intracranial-srt-for-egfr-mutant-nsclc-with-symptomatic-brain-metastases-43781https://curecurrent.com/trials/a-retrospective-real-world-study-based-on-rationale-307-43782https://curecurrent.com/trials/the-mylunghealth-study-protocol-engaging-patients-to-enable-interoperable-lung-cancer-decision-support-at-scale-43783https://curecurrent.com/trials/durvalumab-as-consolidation-for-patients-ls-sclc-43784https://curecurrent.com/trials/study-on-the-efficacy-and-safety-of-jskn016-as-neoadjuvant-therapy-in-resectable-stage-ii-iii-non-small-cell-lung-cancer-43785https://curecurrent.com/trials/screening-and-multiple-intervention-on-lung-epidemics-43786https://curecurrent.com/trials/kras-specific-autologous-tcr-t-cell-therapy-for-kras-mutation-in-advanced-solid-tumors-43787https://curecurrent.com/trials/phase-ib-ii-trial-of-envafolimab-plus-lenvatinib-for-subjects-with-solid-tumors-43788https://curecurrent.com/trials/phase-iii-study-of-envafolimab-versus-placebo-plus-chemotherapy-in-resectable-stage-iii-nsclc-43789https://curecurrent.com/trials/a-mobile-patient-health-technology-intervention-for-improving-lung-cancer-screening-rates-in-eligible-high-risk-patients-43790https://curecurrent.com/trials/a-study-of-imu-201-pd1-vaxx-a-b-cell-immunotherapy-in-adults-with-non-small-cell-lung-cancer-43791https://curecurrent.com/trials/clinical-study-of-lung-protective-ventilation-strategies-and-tumor-microenvironment-43792https://curecurrent.com/trials/university-of-michigan-copd-identification-through-lung-cancer-screening-cohort-study-map2-43793https://curecurrent.com/trials/fulzerasib-sequential-sintilimab-plus-platinum-doublet-neoadjuvant-therapy-for-resectable-kras-g12c-mutant-nsclc-43794https://curecurrent.com/trials/circulating-tumor-cells-in-lung-cancer-screening-43795https://curecurrent.com/trials/osimertinib-plus-capivasertib-in-nsclc-with-pik3ca-akt1-pten-alterations-following-prior-1l-osimertinib-43796https://curecurrent.com/trials/an-open-label-study-of-encorafenib-binimetinib-in-patients-with-brafv600-mutant-non-small-cell-lung-cancer-43797https://curecurrent.com/trials/colorectal-cancer-screening-in-cystic-fibrosis-43798https://curecurrent.com/trials/community-support-program-for-lung-cancer-screening-volume-ii-43799https://curecurrent.com/trials/study-of-ds-1062a-in-advanced-or-metastatic-non-small-cell-lung-cancer-with-actionable-genomic-alterations-tropion-lung0-43800https://curecurrent.com/trials/dll3-directed-chimeric-antigen-receptor-t-cells-in-subjects-with-extensive-stage-small-cell-lung-cancer-43801https://curecurrent.com/trials/phase-i-trial-of-atezolizumab-and-interleukin-12-gene-therapy-in-metastatic-non-small-cell-lung-cancer-with-progression-43802https://curecurrent.com/trials/family-supported-palliative-care-in-advanced-lung-cancer-43803https://curecurrent.com/trials/intrathecal-pemetrexed-for-leptomeningeal-metastasis-in-egfr-mutant-nsclc-43804https://curecurrent.com/trials/shr-a1811-ak112-in-her2-altered-advanced-metastatic-nsclc-43805https://curecurrent.com/trials/pet-ct-predicting-lymph-nodes-metastasis-43806https://curecurrent.com/trials/study-of-healthy-donor-fmt-hdfmt-and-pembrolizumab-in-relapsed-refractory-r-r-pd-l1-positive-nsclc-43807https://curecurrent.com/trials/using-e-nose-technology-to-track-treatment-response-in-people-with-non-small-cell-lung-cancer-43808https://curecurrent.com/trials/targeted-treatment-for-ret-fusion-positive-advanced-non-small-cell-lung-cancer-a-lung-map-treatment-trial-43809https://curecurrent.com/trials/diagnostic-value-and-safety-of-combined-biopsy-for-mediastinal-metastasis-of-lung-cancer-43810https://curecurrent.com/trials/a-study-to-learn-about-pf-07921585-alone-or-with-other-anti-cancer-medicines-in-people-with-cancer-43811https://curecurrent.com/trials/targeting-pd-l1-and-tigit-in-tumors-with-tertiary-lymphoid-structures-43812https://curecurrent.com/trials/megestrol-acetate-for-first-line-treatment-of-malnourished-non-small-cell-lung-cancer-43813https://curecurrent.com/trials/galvanize-aliya-ex-pulsed-electric-field-pef-treat-and-resect-study-43814https://curecurrent.com/trials/unveiling-malnutrition-and-metabolic-changes-in-lung-cancer-patients-setting-the-basis-for-precision-nutrition-models-43815https://curecurrent.com/trials/accelerated-pulmonary-rehabilitation-in-the-preoperative-period-43816https://curecurrent.com/trials/low-glucose-high-fat-intake-dietary-regimen-as-a-tool-for-empowering-diagnostic-accuracy-of-2-18f-fdg-pet-ct-in-lepidic-43817https://curecurrent.com/trials/magnetic-resonance-imaging-of-the-lung-oncological-applications-43818https://curecurrent.com/trials/a-prospective-multicenter-exploratory-clinical-study-on-consolidation-therapy-with-tislelizumab-combined-with-nintedanib-43819https://curecurrent.com/trials/thoracic-surgery-by-the-medtronic-hugo-robotic-system-43820https://curecurrent.com/trials/microbiota-and-the-lung-cancer-43821https://curecurrent.com/trials/association-between-galectin-3-levels-and-outcomes-in-patients-with-renal-cell-carcinoma-transitional-cell-carcinoma-non-43822https://curecurrent.com/trials/donor-natural-killer-cells-cyclophosphamide-and-etoposide-in-treating-children-and-young-adults-with-relapsed-or-refract-43823https://curecurrent.com/trials/benefit-of-spectral-information-in-patients-suspected-for-lung-cancer-43824https://curecurrent.com/trials/andamertinib-with-or-without-platinum-doublet-chemotherapy-versus-platinum-doublet-chemotherapy-in-patients-with-nsclc-h-43825https://curecurrent.com/trials/a-phase-1-study-of-cpo301-in-adult-patients-with-advanced-or-metastatic-solid-tumors-43826https://curecurrent.com/trials/post-operative-medium-chain-triglyceride-diet-may-reduce-hospital-stay-following-lung-resection-43827https://curecurrent.com/trials/detection-of-electrodermal-activity-in-pain-2-43828https://curecurrent.com/trials/prediction-of-outcome-to-neoadjuvant-therapy-in-non-small-cell-lung-cancer-nsclc-43829https://curecurrent.com/trials/fiber-boost-randomized-controlled-trial-43830https://curecurrent.com/trials/liquid-biopsy-monitoring-of-egfr-t790m-in-advanced-non-small-cell-lung-cancer-43831https://curecurrent.com/trials/clinical-outcomes-and-quality-of-life-after-minimally-invasive-segmentectomy-versus-lobectomy-for-lung-cancer-43832https://curecurrent.com/trials/a-digital-health-intervention-to-improve-physical-function-and-wellness-of-lung-cancer-survivors-43833https://curecurrent.com/trials/a-study-of-shr-a2009-versus-platinum-based-chemotherapy-in-egfr-mutated-advanced-or-metastatic-nsclc-43834https://curecurrent.com/trials/cascade-lung-cancer-screening-assay-using-delfi-a-clinical-validation-study-in-lung-43835https://curecurrent.com/trials/biobank-for-the-identification-of-biomarkers-in-lung-cancer-bird-biomarkers-in-respiratory-disease-43836https://curecurrent.com/trials/notion-in-home-sampling-of-cytokines-in-immunotherapy-patients-43837https://curecurrent.com/trials/study-of-eftilagimod-alfa-efti-in-combination-with-pembrolizumab-and-chemotherapy-versus-placebo-in-combination-with-pem-43838https://curecurrent.com/trials/study-of-jdq443-in-patients-with-advanced-solid-tumors-harboring-the-kras-g12c-mutation-43839https://curecurrent.com/trials/progel-platinum-for-air-leak-reduction-after-vats-lobectomy-for-nsclc-43840https://curecurrent.com/trials/lung-us-for-peep-optimization-in-robotic-radical-prostatectomy-or-cystectomy-patients-43841https://curecurrent.com/trials/effect-of-pre-operative-exercise-training-on-cardiorespiratory-fitness-in-patients-with-locally-advanced-non-small-cell-43842https://curecurrent.com/trials/effect-of-tumor-treating-fields-ttfields-150-khz-concurrent-with-standard-of-care-therapies-for-treatment-of-stage-4-non-43843https://curecurrent.com/trials/lung-cancer-risk-assessment-and-etiology-43844https://curecurrent.com/trials/a-study-evaluating-fmc-376-in-participants-with-kras-g12c-mutated-solid-tumors-43845https://curecurrent.com/trials/lung-cancer-screening-in-high-risk-nonsmokers-by-artificial-intelligence-device-43846https://curecurrent.com/trials/adaptive-phase-1-2-study-of-dual-target-car-nk-cells-in-relapsed-refractory-small-cell-lung-cancer-sclc-43847https://curecurrent.com/trials/a-study-of-df6002-alone-and-in-combination-with-nivolumab-43848https://curecurrent.com/trials/a-study-on-intratumoral-fibrosis-and-sma-expression-in-intrahepatic-cholangiocarcinoma-43849https://curecurrent.com/trials/study-of-df6215-in-patients-with-advanced-solid-tumors-43850https://curecurrent.com/trials/safety-and-efficacy-of-aon-d21-in-severe-community-acquired-pneumonia-43851https://curecurrent.com/trials/factors-sustaining-tobacco-abstinence-in-cancer-patients-treated-with-radio-chemotherapy-or-radiotherapy-43852https://curecurrent.com/trials/comparing-the-efficacy-and-safety-of-a-new-additional-treatment-with-tislelizumab-in-non-small-cell-lung-cancer-nsclc-43853https://curecurrent.com/trials/outside-the-cage-otc-robotic-lobectomy-43854https://curecurrent.com/trials/a-phase-i-iia-study-to-investigate-the-safety-tolerability-pharmacokinetics-and-efficacy-of-azd0022-as-monotherapy-and-i-43855https://curecurrent.com/trials/sonidegib-and-pembrolizumab-in-treating-patients-with-advanced-solid-tumors-43856https://curecurrent.com/trials/effects-of-different-oxygen-concentrations-on-pulmonary-complications-in-patients-undergoing-radical-resection-of-esopha-43857https://curecurrent.com/trials/immune-response-to-immunotherapy-in-lung-cancer-study-of-sputum-and-blood-samples-43858https://curecurrent.com/trials/survey-of-brigatinib-used-to-treat-people-with-non-small-cell-lung-cancer-43859https://curecurrent.com/trials/neoadjuvant-pembrolizumab-43860https://curecurrent.com/trials/a-vaccine-cimavax-egf-for-the-prevention-of-lung-cancer-development-or-recurrence-43861https://curecurrent.com/trials/a-multi-center-non-interventional-prospective-study-of-durvalumab-in-unresectable-locally-advanced-nsclc-in-routine-clin-43862https://curecurrent.com/trials/assessing-the-effectiveness-of-low-dose-computed-tomography-in-lung-cancer-screening-for-high-risk-smokers-a-randomized-43863https://curecurrent.com/trials/integrated-genomics-in-oncogene-driven-nsclc-with-acquired-resistance-43864https://curecurrent.com/trials/alrizomadlin-apg-115-in-subjects-with-bap1-cancer-syndrome-and-early-stage-mesothelioma-43865https://curecurrent.com/trials/pulmosalud-multimodal-program-for-prehabilitation-and-early-home-rehabilitation-in-patients-with-lung-cancer-43866https://curecurrent.com/trials/correlation-between-tissue-and-plasmatic-egfr-in-cbnpc-with-egfr-mutation-or-predictive-factor-of-egfr-mutation-43867https://curecurrent.com/trials/insights-on-dissemination-of-lung-cancer-43868https://curecurrent.com/trials/clinical-outcomes-and-immunotherapy-in-lung-cancer-with-pulmonary-fibrosis-43869https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-vs-placebo-for-participants-with-non-small-cell-lung-cancer-after-resection-with-or-witho-43870https://curecurrent.com/trials/lurbinectedin-with-berzosertib-an-atr-kinase-inhibitor-in-small-cell-cancers-and-high-grade-neuroendocrine-cancers-43871https://curecurrent.com/trials/limertinib-plus-carboplatin-and-etoposide-for-egfr-mutant-nsclc-with-sclc-transformation-after-egfr-tki-progression-43872https://curecurrent.com/trials/phase-ii-neoadjuvant-study-of-garsorasib-followed-by-ivonescimab-plus-chemotherapy-in-resectable-stage-iia-iiib-kras-g12-43873https://curecurrent.com/trials/feasibility-study-to-investigate-rectal-mucus-in-aero-digestive-tract-cancer-43874https://curecurrent.com/trials/phase-ii-study-evaluating-strategies-of-lung-surveillance-of-patients-operated-of-high-grade-soft-tissue-sarcoma-43875https://curecurrent.com/trials/alcohol-and-tobacco-consumption-in-patients-with-head-and-neck-or-lung-cancer-43876https://curecurrent.com/trials/experiences-w-attitudes-towards-immune-chckpt-inhibitors-in-nsclc-patients-single-center-survey-based-study-43877https://curecurrent.com/trials/sys6090-combination-therapy-in-advanced-lung-cancer-43878https://curecurrent.com/trials/durvalumab-and-tremelimumab-in-combination-with-chemotherapy-in-hiv-infected-patients-with-non-small-cell-lung-cancer-43879https://curecurrent.com/trials/study-of-different-therapeutic-strategies-in-hydatidiform-mole-with-lung-nodule-43880https://curecurrent.com/trials/managed-access-programs-for-inc280-capmatinib-43881https://curecurrent.com/trials/study-of-the-expression-of-met-receptor-fragments-in-non-small-cell-lung-cancers-43882https://curecurrent.com/trials/study-of-durvalumab-tremelimumab-with-chemotherapy-or-durvalumab-with-chemotherapy-or-chemotherapy-alone-for-patients-wi-43883https://curecurrent.com/trials/effects-of-preoperative-rehabilitation-in-patients-resected-for-lung-cancer-43884https://curecurrent.com/trials/a-clinical-trial-on-the-outcomes-of-comprehensive-enhanced-prophylaxis-management-cepm-in-chinese-patients-with-egfr-mut-43885https://curecurrent.com/trials/an-exosomal-mirna-based-liquid-biopsy-for-icc-detection-43886https://curecurrent.com/trials/ascorbate-with-durvalumab-in-non-small-cell-lung-cancer-nsclc-43887https://curecurrent.com/trials/cohort-of-non-small-cell-lung-cancer-with-mutation-of-the-nord-pas-de-calais-cb-npc-43888https://curecurrent.com/trials/act-lung-health-intervention-phase-two-43889https://curecurrent.com/trials/advance-care-planning-in-the-emergency-department-43890https://curecurrent.com/trials/study-of-furmonertinib-in-patients-with-advanced-or-metastatic-non-small-cell-lung-cancer-nsclc-with-activating-includin-43891https://curecurrent.com/trials/alcohol-and-tobacco-consumption-in-patients-with-head-and-neck-or-lung-cancer-interest-of-an-addiction-treatment-43892https://curecurrent.com/trials/study-of-vudalimab-or-pembrolizumab-in-combination-with-chemotherapy-as-first-line-treatment-in-patients-with-advanced-n-43893https://curecurrent.com/trials/liquid-biopsy-using-exosomal-mirna-enables-risk-stratification-of-potential-metastasis-in-patients-with-intrahepatic-cho-43894https://curecurrent.com/trials/study-of-ono-7475-in-combination-with-osimertinib-in-egfr-gene-mutation-positive-non-small-cell-lung-cancer-43895https://curecurrent.com/trials/prospective-multicentre-study-for-the-application-of-telomere-measurement-technology-as-a-tool-for-lung-cancer-diagnosis-43896https://curecurrent.com/trials/dual-target-car-nk-cells-directed-against-msln-egfr-or-her2-in-advanced-nsclc-43897https://curecurrent.com/trials/calprotectin-a-biomarker-of-covid-19-severity-calpro-43898https://curecurrent.com/trials/video-double-lumen-tube-for-secondary-pulmonary-resection-43899https://curecurrent.com/trials/anti-pd-1-re-challenge-after-immune-priming-by-ipilimumab-and-immune-boosting-by-radiotherapy-in-advanced-nsclc-43900https://curecurrent.com/trials/a-study-of-pembrolizumab-and-radiation-therapy-in-people-with-mesothelioma-43901https://curecurrent.com/trials/anesthesia-comparison-in-early-stage-small-nsclc-a-multicenter-rct-43902https://curecurrent.com/trials/a-trial-of-regorafenib-plus-lorigerlimab-as-neoadjuvant-therapy-for-patients-with-pmmr-mss-resectable-lung-limited-metas-43903https://curecurrent.com/trials/liquid-biopsy-based-ngs-in-newly-diagnosed-nsclc-43904https://curecurrent.com/trials/ibi351-plus-cetuximab-in-untreated-advanced-non-small-cell-lung-cancer-with-kras-g12c-mutation-43905https://curecurrent.com/trials/the-effect-of-toripalimab-plus-radiotherapy-in-patients-with-operable-stage-ii-iiia-n-non-small-cell-lung-cancer-43906https://curecurrent.com/trials/a-study-evaluating-the-safety-and-efficacy-of-neoadjuvant-and-adjuvant-tiragolumab-plus-atezolizumab-with-or-without-pla-43907https://curecurrent.com/trials/biomarker-directed-trial-of-temozolomide-and-stenoparib-in-relapsed-sclc-43908https://curecurrent.com/trials/feasibility-of-targeted-bronchial-washing-for-molecular-testing-by-next-generation-sequencing-in-early-stage-lung-cancer-43909https://curecurrent.com/trials/a-phase-iii-study-of-hs-20093-injection-combined-with-adebrelimab-versus-docetaxel-in-previously-treated-patients-with-a-43910https://curecurrent.com/trials/orient-31-regimen-in-combination-with-sbrt-for-egfr-mutant-metastatic-nsclc-after-first-line-third-generation-egfr-tkis-43911https://curecurrent.com/trials/a-hierarchical-multi-modal-ai-framework-for-pathological-and-genetic-subtyping-of-lung-cancer-based-on-pet-ct-imaging-43912https://curecurrent.com/trials/assessing-social-determinants-of-health-to-increase-cancer-screening-43913https://curecurrent.com/trials/priming-immunotherapy-in-advanced-disease-with-radiation-43914https://curecurrent.com/trials/application-of-68ga-ga-ni-fapi-04-pet-ct-imaging-in-fibroblast-activation-protein-related-diseases-43915https://curecurrent.com/trials/evaluation-of-impedance-cardiography-for-assessing-hemodynamic-shifts-in-patients-with-la-nsclc-during-treatment-43916https://curecurrent.com/trials/tunlametinib-combination-therapy-in-kras-mutated-unresectable-locally-advanced-or-metastatic-non-small-cell-lung-cancer-43917https://curecurrent.com/trials/first-in-human-study-of-interferon-y-pet-imaging-to-assess-response-to-immunotherapy-43918https://curecurrent.com/trials/evaluation-of-endobronchial-ultrasound-needle-cleaning-techniques-and-their-impact-on-specimen-contamination-43919https://curecurrent.com/trials/understanding-non-small-cell-lung-cancer-patient-characteristics-treatment-patterns-and-outcomes-43920https://curecurrent.com/trials/pembrolizumab-and-concurrent-chemoradiotherapy-or-radiation-therapy-in-treating-patients-with-small-cell-lung-cancer-43921https://curecurrent.com/trials/pemetrexed-free-vs-pemetrexed-based-immunochemotherapy-in-metastatic-ttf-1-negative-lung-adenocarcinoma-43922https://curecurrent.com/trials/an-open-label-single-arm-dose-escalation-phase-i-study-evaluating-the-safety-tolerability-and-preliminary-efficacy-of-ed-43923https://curecurrent.com/trials/efficacy-and-safety-of-hgxjt-in-bone-metastatic-nsclc-patients-43924https://curecurrent.com/trials/phase-iii-multicenter-randomized-controlled-clinical-study-of-three-dimensional-radiotherapy-for-primary-tumors-in-non-o-43925https://curecurrent.com/trials/the-cyberchallenge-trial-how-much-is-too-much-what-is-the-role-of-cyberknife-radiosurgery-in-patients-with-multiple-brai-43926https://curecurrent.com/trials/daratumumab-in-stk11-mutated-nsclc-43927https://curecurrent.com/trials/a-study-to-learn-about-lorlatinib-in-patients-with-non-small-cell-lung-cancer-which-could-not-be-controlled-43928https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-adjuvant-tislelizumab-in-high-risk-stage-i-nsclc-43929https://curecurrent.com/trials/a-study-of-yl202-in-patients-with-advanced-solid-tumors-43930https://curecurrent.com/trials/ak112-and-ak104-with-or-without-chemotherapy-in-advanced-non-small-cell-lung-cancer-43931https://curecurrent.com/trials/ak112-in-advanced-non-small-cell-lung-cancer-43932https://curecurrent.com/trials/hepatic-arterial-infusion-chemotherapy-haic-combined-with-durvalumab-and-lenvatinib-in-patients-with-locally-advanced-or-43933https://curecurrent.com/trials/pembrolizumab-and-stereotactic-radiosurgery-for-melanoma-or-non-small-cell-lung-cancer-brain-metastases-43934https://curecurrent.com/trials/therapy-for-advanced-nsclc-with-egfr-19delins-mutation-43935https://curecurrent.com/trials/study-of-ak119-and-ak112-with-or-without-chemotherapy-for-nsclc-patients-43936https://curecurrent.com/trials/ctdna-mrd-guided-escalation-of-ivonescimab-and-docetaxel-in-advanced-nsclc-with-long-term-responses-to-first-line-immuno-43937https://curecurrent.com/trials/pulmonary-magnetic-resonance-guided-online-adaptive-radiotherapy-of-locally-advanced-non-small-cell-lung-cancer-43938https://curecurrent.com/trials/rna-lipid-particles-targeting-pediatric-recurrent-intracranial-malignancies-and-other-systemic-solid-tumors-43939https://curecurrent.com/trials/snb-101-for-treatment-of-extensive-stage-small-cell-lung-cancer-43940https://curecurrent.com/trials/stereotactic-radiotherapy-sbrt-of-lung-metastasis-43941https://curecurrent.com/trials/general-anesthesia-vs-conscious-sedation-for-radial-endobronchial-ultrasound-43942https://curecurrent.com/trials/implementing-circulating-tumor-dna-analysis-at-initial-diagnosis-to-improve-management-of-advanced-nsclc-patients-43943https://curecurrent.com/trials/liquid-biopsy-genotyping-using-oncomine-precision-assay-gx-in-advanced-nsclc-43944https://curecurrent.com/trials/phase-i-study-of-tolododekin-alfa-ank-101-in-advanced-solid-tumors-43945https://curecurrent.com/trials/precision-medicine-randomized-clinical-trial-comparing-molecular-tumor-board-assisted-care-to-usual-care-43946https://curecurrent.com/trials/study-of-jyp0015-in-patients-with-advanced-solid-tumors-harboring-specific-mutations-in-ras-43947https://curecurrent.com/trials/18f-fluoroazomycin-arabinoside-18f-faza-in-lung-cancer-43948https://curecurrent.com/trials/targeting-odc-as-an-immunotherapeutic-target-in-stk11-lkb1-pathway-deficient-nsclc-dfmo-43949https://curecurrent.com/trials/qls5132-combination-therapy-in-advanced-solid-tumors-43950https://curecurrent.com/trials/studies-of-phenotypic-and-functional-characteristics-of-circulating-neutrophil-subpopulations-in-patients-with-lung-canc-43951https://curecurrent.com/trials/pd-l1-targeting-peptide-probe-for-pet-imaging-of-solid-tumor-43952https://curecurrent.com/trials/a-phase-ib-study-of-rc148-as-monotherapy-or-combination-for-locally-advanced-or-metastatic-nsclc-43953https://curecurrent.com/trials/phase-ii-trial-of-lung-chemoemobolization-43954https://curecurrent.com/trials/telephone-based-physical-activity-coaching-or-self-monitored-physical-activity-to-improve-physical-function-in-older-adu-43955https://curecurrent.com/trials/a-study-of-ak112-as-consolidation-treatment-for-patients-with-limited-stage-small-cell-lung-cancer-who-have-not-progress-43956https://curecurrent.com/trials/an-exploratory-study-of-ql1706-plus-chemotherapy-in-perioperative-nsclc-43957https://curecurrent.com/trials/pleural-effusion-biomarkers-in-lung-adenocarcinoma-patients-43958https://curecurrent.com/trials/a-study-of-bl-m07d1-in-combination-with-pembrolizumab-in-patients-with-unresectable-locally-advanced-or-metastatic-her2-43959https://curecurrent.com/trials/early-feasibility-study-efs-of-the-carol-for-treatment-of-lung-cancer-stage-1-43960https://curecurrent.com/trials/short-neoadjuvant-hemithoracic-imrt-for-mpm-43961https://curecurrent.com/trials/an-exploratory-study-of-atezolizumab-and-bevacizumab-in-hepatocellular-carcinoma-and-non-small-cell-lung-cancer-with-liv-43962https://curecurrent.com/trials/minnelide-and-osimertinib-for-the-treatment-of-advanced-egfr-mutated-non-small-cell-lung-cancer-43963https://curecurrent.com/trials/u3-1402-in-metastatic-or-unresectable-non-small-cell-lung-cancer-43964https://curecurrent.com/trials/a-study-of-pralsetinib-versus-standard-of-care-for-first-line-treatment-of-advanced-non-small-cell-lung-cancer-nsclc-43965https://curecurrent.com/trials/study-of-dcc-3084-in-participants-with-advanced-malignancies-driven-by-the-mitogen-activated-protein-kinase-mapk-pathway-43966https://curecurrent.com/trials/effects-of-pranayama-breathing-technique-on-stress-level-sleep-quality-and-quality-of-life-among-older-adults-43967https://curecurrent.com/trials/disease-burden-transition-of-mucormycosis-in-hematologic-malignancies-population-across-covid-19-era-a-single-center-com-43968https://curecurrent.com/trials/maximizing-lymph-node-dissection-on-fresh-and-fixed-lung-cancer-resection-specimens-43969https://curecurrent.com/trials/talazoparib-and-thoracic-rt-for-es-sclc-43970https://curecurrent.com/trials/observational-prospective-multi-centric-study-exploring-her2-mutations-incidence-and-therapeutic-management-in-ansclc-43971https://curecurrent.com/trials/a-feasibility-study-evaluating-surgery-for-mesothelioma-after-radiation-therapy-using-extensive-pleural-resection-43972https://curecurrent.com/trials/a-study-of-selpercatinib-after-surgery-or-radiation-in-participants-with-non-small-cell-lung-cancer-nsclc-43973https://curecurrent.com/trials/18f-fdg-pet-ct-radiomics-models-for-precision-diagnosis-and-prognosis-in-nsclc-43974https://curecurrent.com/trials/implementation-strategies-for-monitoring-adherence-in-real-time-43975https://curecurrent.com/trials/curatively-intended-thoracic-reirradiation-43976https://curecurrent.com/trials/phase-3-clinical-study-of-ak112-for-nsclc-patients-43977https://curecurrent.com/trials/a-study-of-fz-ad005-in-patients-with-advanced-solid-tumors-43978https://curecurrent.com/trials/observing-patients-with-palliative-asymptomatic-centrally-located-advanced-non-small-cell-lung-carcinoma-nsclc-43979https://curecurrent.com/trials/evaluating-a-bidirectional-priming-intervention-for-goals-of-care-communication-in-oncology-43980https://curecurrent.com/trials/durvalumab-and-ablative-radiation-in-small-cell-lung-cancer-dares-43981https://curecurrent.com/trials/palliative-thoracic-immunort-43982https://curecurrent.com/trials/sys6010-versus-docetaxel-for-previously-treated-egfr-wild-type-nsclc-phase-43983https://curecurrent.com/trials/integrative-analysis-of-tumor-microenvironment-and-optimization-of-immunotherapy-duration-in-nscl-cancer-patients-43984https://curecurrent.com/trials/concurrent-or-sequential-immunotherapy-and-radiation-therapy-in-patients-with-metastatic-lung-cancer-43985https://curecurrent.com/trials/utility-of-caml-as-diagnostic-for-early-stage-lung-cancer-43986https://curecurrent.com/trials/from-presentation-to-diagnosis-patterns-of-pleural-effusion-43987https://curecurrent.com/trials/concurrent-chemoradiotherapy-combined-with-toripalimab-and-surufatinib-in-the-treatment-of-limited-stage-small-cell-lung-43988https://curecurrent.com/trials/engagement-of-veterans-with-lung-cancer-43989https://curecurrent.com/trials/magnesium-vs-dexmedetomidine-in-turbt-under-spinal-anesthesia-43990https://curecurrent.com/trials/is-there-a-benefit-from-addition-of-physical-exercise-to-diet-restriction-limitation-in-pcos-women-with-asthma-43991https://curecurrent.com/trials/a-study-of-shr-1210-in-combination-with-apatinib-in-advanced-non-small-cell-lung-cancer-nsclc-43992https://curecurrent.com/trials/to-conduct-multi-omics-integrated-studies-in-peripheral-blood-such-as-fragment-omics-metabolomics-and-epigenetics-and-es-43993https://curecurrent.com/trials/a-phase-3-study-of-in10018-in-combination-with-d-1553-versus-standard-therapy-for-first-line-non-squamous-non-small-cell-43994https://curecurrent.com/trials/an-phase-i-trial-of-a-car-t-cell-infusion-c-car031-in-participants-with-gpc3-advanced-metastatic-squamous-cell-lung-canc-43995https://curecurrent.com/trials/leveraging-lung-cancer-screening-to-optimize-screening-outcomes-and-copd-management-copd-in-lcs-registry-43996https://curecurrent.com/trials/anti-ctla4-nf-mab-bms986218-nivolumab-and-stereotactic-body-radiation-therapy-for-the-treatment-of-metastatic-solid-mali-43997https://curecurrent.com/trials/repositioning-immunotherapy-in-vetarans-with-lung-cancer-43998https://curecurrent.com/trials/a-trial-of-ak112-pd-1-vegf-bispecific-antibody-in-patients-with-nsclc-43999https://curecurrent.com/trials/sirolimus-in-combination-with-metronomic-chemotherapy-in-children-with-recurrent-and-or-refractory-solid-and-cns-tumors-44000